Cancer prevention with promising natural products: Mechanisms of action and molecular targets

Anti-Cancer Agents in Medicinal Chemistry

Volumn 12, Issue 10, 2012, Pages 1159-1184

  Pratheeshkumar, Poyil ^a   Sreekala, Chakkenchath ^a   Zhang, Zhuo ^a   Budhraja, Amit ^a   Ding, Songze ^a   Son, Young Ok ^a   Wang, Xin ^a   Hitron, Andrew ^a   Hyun Jung, Kim ^a   Wang, Lei ^a   Lee, Jeong Chae ^a   Shi, Xianglin ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

( ) epigallocatechin 3 gallate; Activator protein 1; Angiogenesis; Apoptosis; Cell cycle arrest; Chemoprevention; Curcumin; Cyclooxygenase (COX) 2; Isothyocynates; Nuclear factor (NF) B; Oxidative stress; Phytochemicals; Resveratrol

Indexed keywords

APIGENIN; CURCUMIN; CYCLIN DEPENDENT KINASE 1; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIGALLOCATECHIN GALLATE; GELATINASE A; GELATINASE B; GENISTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; ISOTHIOCYANIC ACID DERIVATIVE; LYCOPENE; MITOGEN ACTIVATED PROTEIN KINASE; NATURAL PRODUCT; PERILLYL ALCOHOL; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; STAT3 PROTEIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNINDEXED DRUG; URSOLIC ACID; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER PREVENTION; CARCINOGENESIS; CELL CYCLE; CELL SURVIVAL; DRUG MECHANISM; HUMAN; INFLAMMATION; METASTASIS; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; BIOLOGICAL AGENTS; CHEMOPREVENTION; DRUG DISCOVERY; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84870166894     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/187152012803833035     Document Type: Article

References (451)

1. Amin, A.; Kucuk, O.; Khuri, F. R.; Shin, D. M. Perspectives for cancer prevention with natural compounds. J. Clin. Oncol., 2009, 27(16), 2712.
2. Chen, D.; Dou, Q. P. Tea polyphenols and their roles in cancer prevention and chemotherapy. Int. J. Mol. Sci., 2008, 9(7), 1196-1206.
3. Mondal, S.; Bandyopadhyay, S.; Ghosh, M.; Mukhopadhyay, S.; Roy, S.; Mandal, C. Natural Products: Promising Resources For Cancer Drug Discovery. Anticancer Agents Med.Chem., 2011. [Epub ahead of print]
4. Sultana, N. Clinically useful anticancer, antitumor, and antiwrinkle agent, ursolic acid and related derivatives as medicinally important natural product. J. Enzyme Inhib. Med. Chem., 2011, (00), 1-27.
5. Nishino, H.; Tokuda, H.; Satomi, Y.; Masuda, M.; Onozuka, M.; Yamaguchi, S.; Takayasu, J.; Tsuruta, J.; Takemura, M.; Ii, T. Cancer chemoprevention by phytochemicals and their related compounds. Asian Pac. J. Cancer Prev., 2000, 1(1), 49-55.
6. Ullah, M. F.; Ahmad, A.; Zubair, H.; Khan, H. Y.; Wang, Z.; Sarkar, F. H.; Hadi, S. M. Soy isoflavone genistein induces cell death in breast cancer cells through mobilization of endogenous copper ions and generation of reactive oxygen species. Mol. Nutr. Food Res., 2011, 55(4), 553-9.
7. Nigam, N.; George, J.; Srivastava, S.; Roy, P.; Bhui, K.; Singh, M.; Shukla, Y. Induction of apoptosis by [6]-gingerol associated with the modulation of p53 and involvement of mitochondrial signaling pathway in B [a] P-induced mouse skin tumorigenesis. Cancer Chemother. Pharmacol., 2010, 65(4), 687-696.
8. Surh, Y. J.; Chun, K. S. Cancer chemopreventive effects of curcumin. In. The Molecular Targets and Therapeutic Uses of urcumin in Health and Disease. Aggarwal, B. B.; Surh Y. J.; Shishodia, S. Springer: 2007, 149-172.
9. Shu, L.; Cheung, K. L.; Khor, T. O.; Chen, C.; Kong, A. N. Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis. Cancer Metastasis. Rev., 2010, 29(3), 483-502.
10. Surh, Y. J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev.Cancer., 2003, 3(10), 768-780.
11. de Kok, T. M. C. M.; de Waard, P.; Wilms, L. C.; van Breda, S. G. J. Antioxidative and antigenotoxic properties of vegetables and dietary phytochemicals: The value of genomics biomarkers in molecular epidemiology. Mol.Nutr. Food Res., 2010, 54(2), 208-217.
12. Rajasekaran, S. A. Therapeutic potential of curcumin in gastrointestinal diseases. World J. Gastrointest. Pathophysiol. 2011, 2(1), 1-14.
13. Menon, V. P.; Sudheer, A. R. Antioxidant and anti-inflammatory properties of curcumin. The Molecular Targets and Therapeutic Uses of urcumin in Health and Disease. Aggarwal, B. B.; Surh Y. J.; Shishodia, S. Springer: 2007, 105-125.
14. Aggarwal, B. B.; Sung, B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol.Sci., 2009, 30(2), 85-94.
15. Thangapazham, R. L.; Sharma, A.; Maheshwari, R. K. Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J., 2006, 8(3), 443-449.
16. Anand, P.; Sundaram, C.; Jhurani, S.; Kunnumakkara, A. B.; Aggarwal, B. B. Curcumin and cancer: An. Cancer lett., 2008, 267(1), 133-164.
17. Park, J.; Conteas, C. N. Anti-carcinogenic properties of curcumin on colorectal cancer. World J.Gastrointest. Oncol., 2010, 2(4), 169.
18. Subramaniam, D.; Ramalingam, S.; Linehan, D. C.; Dieckgraefe, B. K.; Postier, R. G.; Houchen, C. W.; Jensen, R. A.; Anant, S. RNA Binding Protein CUGBP2/CELF2 Mediates Curcumin-Induced Mitotic Catastrophe of Pancreatic Cancer Cells. PloS one., 2011, 6(2), e16958.
19. Duarte, V. M.; Han, E.; Veena, M. S.; Salvado, A.; Suh, J. D.; Liang, L. J.; Faull, K. F.; Srivatsan, E. S.; Wang, M. B. Curcumin enhances the effect of cisplatin in suppression of head and neck squamous cell carcinoma via inhibition of IKK protein of the NF B pathway. Mol.Cancer Ther., 2010, 9(10), 2665-2675.
20. Cheng, C. Y.; Lin, Y. H.; Su, C. C. Curcumin inhibits the proliferation of human hepatocellular carcinoma J5 cells by inducing endoplasmic reticulum stress and mitochondrial dysfunction. Int.J.Mol.Med., 2010, 26(5), 673-678.
21. Mudduluru, G.; George-William, J. N.; Muppala, S.; Asangani, I. A.; Regalla, K.; Nelson, L. D.; Allgayer, H. Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Biosci. Rep., 2011, 31(3), 185-197.
22. Kim, J. H.; Xu, C.; Keum, Y. S.; Reddy, B.; Conney, A.; Kong, A. N. T. Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with -phenylethyl isothiocyanate and curcumin. Carcinogenesis., 2006, 27(3), 475-482.
23. Menon, L. G.; Kuttan, R.; Kuttan, G. Anti-metastatic activity of curcumin and catechin. Cancer lett., 1999, 141(1-2), 159-165.
24. Rao, C. V. Regulation of COX and LOX by curcumin. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. 2007, 213-226.
25. Kim, Y. S.; Young, M. R.; Bobe, G.; Colburn, N. H.; Milner, J. A. Bioactive food components, inflammatory targets, and cancer prevention. Cancer Prev. Res (Phila)., 2009, 2(3), 200-208.
26. Wang, Z.; Zhang, Y.; Banerjee, S.; Li, Y.; Sarkar, F. H. Notch 1 down regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer., 2006, 106(11), 2503-2513.
27. Ravindran, J.; Prasad, S.; Aggarwal, B. B. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J., 2009, 11(3), 495-510.
28. Su, C. C.; Chen, G. W. E. I.; Lin, J. G.; Wu, L. I. I. T. Z. U.; Chung, J. G. Curcumin inhibits cell migration of human colon cancer colo 205 cells through the inhibition of nuclear factor kappa B/p65 and down-regulates cyclooxygenase-2 and matrix metalloproteinase-2 expressions. Anticancer Res., 2006, 26(2A), 1281-1288.
29. Shankar, S.; Ganapathy, S.; Chen, Q.; Srivastava, R. K. Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis. Mol. Cancer., 2008, 7(1), 16.
30. Cai, X. Z.; Wang, J.; Li, X.; Wang, G. L.; Liu, F. N.; Cheng, M. S.; Li, F. Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression. Cancer Biol. Ther., 2009, 8(14), 1360-1368.
31. Jaiswal, A. S.; Marlow, B. P.; Gupta, N.; Narayan, S. -Cateninmediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene., 2002, 21(55), 8414-8427.
32. Gagliano, N.; Aldini, G.; Colombo, G.; Rossi, R.; Colombo, R.; Gioia, M.; Milzani, A.; Dalle-Donne, I. The potential of resveratrol against human gliomas. Anticancer Drugs., 2010, 21(2), 140-150.
33. Lee, K. W.; Lee, H. J. The roles of polyphenols in cancer chemoprevention. Biofactors. 2006, 26(2), 105-121.
34. Leonard, S. S.; Xia, C.; Jiang, B. H.; Stinefelt, B.; Klandorf, H.; Harris, G. K.; Shi, X. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun., 2003, 309(4), 1017-1026.
35. Zhu, H. L. Resveratrol and Its Analogues: Promising Antitumor Agents. Anticancer Agents Med. Chem., 2011, 11(5), 479-490.
36. Gupta, S. C.; Kannappan, R.; Reuter, S.; Kim, J. H.; Aggarwal, B. B. Chemosensitization of tumors by resveratrol. Ann. N. Y. Acad. Sci., 2011, 1215(1), 150-160.
37. Benitez, D. A.; Pozo-Guisado, E.; Alvarez-Barrientos, A.; Fernandez-Salguero, P. M.; Castellon, E. A. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines. J. Androl., 2007, 28(2), 282-293.
38. Fulda, S.; Debatin, K. M. Resveratrol-mediated sensitisation to TRAIL-induced apoptosis depends on death receptor and mitochondrial signalling. Eur. J. Cancer., 2005, 41(5), 786-798.
39. Heiss, E. H.; Schilder, Y. D. C.; Dirsch, V. M. Chronic treatment with resveratrol induces redox stress-and ataxia telangiectasiamutated (ATM)-dependent senescence in p53-positive cancer cells. J. Biol. Chem., 2007, 282(37), 26759-26766.
40. Subbaramaiah, K.; Chung, W. J.; Michaluart, P.; Telang, N.; Tanabe, T.; Inoue, H.; Jang, M.; Pezzuto, J. M.; Dannenberg, A. J. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem., 1998, 273(34), 21875-21882.
41. Cao, Y.; Fu, Z. D.; Wang, F.; Liu, H. Y.; Han, R. Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants. J. Asian Nat. Prod. Res., 2005, 7(3), 205-213.
42. Sun, C.; Hu, Y.; Liu, X.; Wu, T.; Wang, Y.; He, W.; Wei, W. Resveratrol downregulates the constitutional activation of nuclear factor-[kappa] B in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of cell cycle, and induction of apoptosis. Cancer Genet. Cytogenet., 2006, 165(1), 9-19.
43. Pozo Guisado, E.; Merino, J. M.; Mulero Navarro, S.; Lorenzo Benayas, M. J.; Centeno, F.; Alvarez Barrientos, A.; Salguero, P. M. F. Resveratrol induced apoptosis in MCF 7 human breast cancer cells involves a caspase independent mechanism with downregulation of Bcl 2 and NF B. Int. J. Cancer., 2005, 115(1), 74-84.
44. Csaki, C.; Mobasheri, A.; Shakibaei, M. Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1beta-induced NF-kappaB-mediated inflammation and apoptosis. Arthritis Res. Ther., 2009, 11(6), R165.
45. Estrov, Z.; Shishodia, S.; Faderl, S.; Harris, D.; Van, Q.; Kantarjian, H. M.; Talpaz, M.; Aggarwal, B. B. Resveratrol blocks interleukin-1 -induced activation of the nuclear transcription factor NF-B, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood., 2003, 102(3), 987-995.
46. Yu, H.; Pan, C.; Wu, W.; Zhao, S.; Zhang, H. Effects of resveratrol on matrix metalloproteinase-9 expression in hepatoma cells. Zhong Xi Yi Jie He Xue Bao., 2008, 6(3), 270-273.
47. Athar, M.; Back, J. H.; Kopelovich, L.; Bickers, D. R.; Kim, A. L. Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. Arch. Biochem. Biophys., 2009, 486(2), 95-102.
48. Fulda, S. Modulation of apoptosis by natural products for cancer therapy. Planta Med., 2010, 76(11), 1075-1079.
49. Shaw, R. J.; Cantley, L. C. Ras, PI (3) K and mTOR signalling controls tumour cell growth. Nature., 2006, 441(7092), 424-430.
50. Zhou, H.; Luo, Y.; Huang, S. Updates of mTOR inhibitors. Anticancer Agents Med. Chem., 2010, 10(7), 571-581.
51. Kim, A. L.; Zhu, Y.; Zhu, H.; Han, L.; Kopelovich, L.; Bickers, D. R.; Athar, M. Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP 1 signalling pathways. Exp. Dermatol., 2006, 15(7), 538-546.
52. Gill, C.; Walsh, S. E.; Morrissey, C.; Fitzpatrick, J. M.; Watson, R. W. G. Resveratrol sensitizes androgen independent prostate cancer cells to death receptor mediated apoptosis through multiple mechanisms. Prostate., 2007, 67(15), 1641-1653.
53. Miloso, M.; Bertelli, A. A. E.; Nicolini, G.; Tredici, G. Resveratrolinduced activation of the mitogen-activated protein kinases, ERK1 and ERK2, in human neuroblastoma SH-SY5Y cells. Neurosci. Lett., 1999, 264(1-3), 141-144.
54. Kundu, J. K.; Shin, Y. K.; Surh, Y. J. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skinin vivo: NF-[kappa] B and AP-1 as prime targets. Biochem. Pharmacol., 2006, 72(11), 1506-1515.
55. Azios, N. G.; Dharmawardhane, S. F. Resveratrol and estradiol exert disparate effects on cell migration, cell surface actin structures, and focal adhesion assembly in MDA-MB-231 human breast cancer cells. Neoplasia., 2005, 7(2), 128-140.
56. Patel, D.; Shukla, S.; Gupta, S. Apigenin and cancer chemoprevention: Progress, potential and promise (Review). Int. J. Oncol., 2006, 30(1), 233-245.
57. Wei, H.; Tye, L.; Bresnick, E.; Birt, D. F. Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res., 1990, 50(3), 499-502.
58. Birt, D.; Mitchell, D.; Gold, B.; Pour, P.; Pinch, H. Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer Res. 1997, 17(1A), 85-91.
59. Middleton, E.; Kandaswami, C.; Theoharides, T. C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev., 2000, 52(4), 673-751.
60. Myhrstad, M. C. W.; Carlsen, H.; Nordström, O.; Blomhoff, R.; Moskaug, J. Flavonoids increase the intracellular glutathione level by transactivation of the [gamma]-glutamylcysteine synthetase catalytical subunit promoter. Free Radic. Biol. Med., 2002, 32(5), 386-393.
61. Shukla, S.; Gupta, S. Apigenin: a promising molecule for cancer prevention. Pharm. Res., 2010, 27(6), 962-978.
62. Shukla, S., Gupta, S. Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3KAkt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells. Cell Cycle., 2007, 6, 1102-1114.
63. Liang, Y. C.; Huang, Y. T.; Tsai, S. H.; Lin-Shiau, S. Y.; Chen, C. F.; Lin, J. K. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis., 1999, 20(10), 1945.
64. Ujiki, M. B.; Ding, X. Z.; Salabat, M. R.; Bentrem, D. J.; Golkar, L.; Milam, B.; Talamonti, M. S.; Bell, R. H.; Iwamura, T.; Adrian, T. E. Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest. Mol. Cancer. 2006, 5(1), 76.
65. Takagaki, N.; Sowa, Y.; Oki, T.; Nakanishi, R.; Yogosawa, S.; Sakai, T. Apigenin induces cell cycle arrest and p21/WAF1 expression in a p53-independent pathway. Int. J. Oncol., 2005, 26(1), 185-189.
66. McVean, M.; Weinberg, W. C.; Pelling, J. C. A p21waf1 independent pathway for inhibitory phosphorylation of cyclin dependent kinase p34cdc2 and concomitant G2/M arrest by the chemopreventive flavonoid apigenin. Mol. Carcinog., 2002, 33(1), 36-43.
67. Lindenmeyer, F.; Li, H.; Menashi, S.; Soria, C.; Lu, H. Apigenin acts on the tumor cell invasion process and regulates protease production. Nutr. Cancer., 2001, 39(1), 139-147.
68. Caltagirone, S.; Rossi, C.; Poggi, A.; Ranelletti, F. O.; Natali, P. G.; Brunetti, M.; Aiello, F. B.; Piantelli, M. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int. J. Cancer., 2000, 87(4), 595-600.
69. Wang, I. K.; Lin-Shiau, S. Y.; Lin, J. K. Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur. J. Cancer., 1999, 35(10), 1517-1525.
70. Melstrom, L. G.; Salabat, M. R.; Ding, X. Z.; Strouch, M. J.; Grippo, P. J.; Mirzoeva, S.; Pelling, J. C.; Bentrem, D. J. Apigenin Down-Regulates the Hypoxia Response Genes: HIF-1 [alpha], GLUT-1, and VEGF in Human Pancreatic Cancer Cells. J. Surg. Res., 2010, 167(2), 173-81.
71. Balasubramanian, S.; Eckert, R. L. Keratinocyte proliferation, differentiation, and apoptosis--Differential mechanisms of regulation by curcumin, EGCG and apigenin. Toxicol. Appl. Pharmacol., 2007, 224(3), 214-219.
72. Chen, D.; Landis-Piwowar, K. R.; Chen, M. S.; Dou, Q. P. Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts. Breast Cancer Res. 2007, 9(6), R80.
73. Mounho, B. J.; Thrall, B. D. The extracellular signal-regulated kinase pathway contributes to mitogenic and antiapoptotic effects of peroxisome proliferators in vitro. Toxicol. Appl. Pharmacol., 1999, 159(2), 125-133.
74. Kelly, G. Quercetin monograph. Alternative medicine review: a journal of clinical therapeutic. 2011, 16(2), 172.
75. Yang, C. S.; Landau, J. M.; Huang, M. T.; Newmark, H. L. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu. Rev. Nutr., 2001, 21(1), 381-406.
76. Bors, W.; Heller, W.; Michel, C.; Saran, M. [36] Flavonoids as antioxidants: Determination of radical-scavenging efficiencies. Methods Enzymol., 1990, 186, 343-355.
77. Prior, R. L. Fruits and vegetables in the prevention of cellular oxidative damage. Am. J. Clin. Nutr., 2003, 78(3), 570S.
78. Day, A. J.; Bao, Y.; Morgan, M. R. A.; Williamson, G. Conjugation position of quercetin glucuronides and effect on biological activity. Free Radic. Biol. Med., 2000, 29(12), 1234-1243.
79. Lamson, D.; Brignall, M. Antioxidants and cancer, part 3: quercetin. Alternative medicine review: a journal of clinical therapeutic. 2000, 5(3), 196.
80. Ferry, D. R.; Smith, A.; Malkhandi, J.; Fyfe, D. W.; deTakats, P. G.; Anderson, D.; Baker, J.; Kerr, D. J. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin. Cancer Res., 1996, 2(4), 659.
81. Manjeet, K. R.; Ghosh, B. Quercetin inhibits LPS-induced nitric oxide and tumor necrosis factor-alpha production in murine macrophages. Int. J. Immunopharmacol., 1999, 21(7), 435.
82. Nair, M. P.; Mahajan, S.; Reynolds, J. L.; Aalinkeel, R.; Nair, H.; Schwartz, S. A.; Kandaswami, C. The Flavonoid Quercetin Inhibits Proinflammatory Cytokine (Tumor Necrosis Factor Alpha) Gene Expression in Normal Peripheral Blood Mononuclear Cells via Modulation of the NF-{kappa}{beta} System. Clin. Vaccine Immunol., 2006, 13(3), 319.
83. Zhang, Q.; Zhao, X. H.; Wang, Z. J. Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. Food Chem. Toxicol., 2008, 46(6), 2042-2053.
84. Kim, W. K.; Bang, M. H.; Kim, E. S.; Kang, N. E.; Jung, K. C.; Cho, H. J.; Park, J. H. Y. Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cells. J. Nutr. Biochem., 2005, 16(3), 155-162.
85. Kim, H. J.; Kim, S. K.; Kim, B. S.; Lee, S. H.; Park, Y. S.; Park, B. K.; Kim, S. J.; Kim, J.; Choi, C.; Kim, J. S. Apoptotic effect of quercetin on HT-29 colon cancer cells via the AMPK signaling pathway. J. Agric. Food Chem., 2010, 58(15), 8643-50.
86. Makita, H.; Tanaka, T.; Fujitsuka, H.; Tatematsu, N.; Satoh, K.; Hara, A.; Mori, H. Chemoprevention of 4-nitroquinoline 1-oxideinduced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone, and quercetin. Cancer Res. 1996, 56(21), 4904-4909.
87. De, S.; Chakraborty, J.; Chakraborty, R.; Das, S. Chemopreventive activity of quercetin during carcinogenesis in cervix uteri in mice. Phytother Res., 2000, 14(5), 347-351.
88. De, S.; Chakraborty, R.; Ghosh, S.; Sengupta, A.; Das, S. Comparative evaluation of cancer chemopreventive efficacy of alpha-tocopherol and quercetin in a murine model. J Exp Clin Cancer Res., 2004, 23(2), 251-258.
89. Khanduja, K.; Gandhi, R.; Pathania, V.; Syal, N. Prevention of Nnitrosodiethylamine-induced lung tumorigenesis by ellagic acid and quercetin in mice. Food Chem Toxicol., 1999, 37(4), 313-318.
90. Yoshida, M.; Sakai, T.; Hosokawa, N.; Marui, N.; Matsumoto, K.; Fujioka, A.; Nishino, H.; Aoike, A. The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett., 1990, 260(1), 10-13.
91. Hofmann, J.; Fiebig, H. H.; Winterhalter, B. R.; Berger, D. P.; Grunicke, H. Enhancement of the antiproliferative activity of cis diamminedichloroplatinum (II) by quercetin. Int. J. Cancer., 1990, 45(3), 536-539.
92. van Rijn, J.; van den Berg, J. Flavonoids as enhancers of x-rayinduced cell damage in hepatoma cells. Clin. Cancer Res., 1997, 3(10), 1775-1779.
93. Cheng, S.; Gao, N.; Zhang, Z.; Chen, G.; Budhraja, A.; Ke, Z.; Son, Y.; Wang, X.; Luo, J.; Shi, X. Quercetin Induces Tumor-Selective Apoptosis through Downregulation of Mcl-1 and Activation of Bax. Clin. Cancer Res., 2010, 16(23), 5679-5691.
94. Olson, E. R.; Melton, T.; Dickinson, S. E.; Dong, Z.; Alberts, D. S.; Bowden, G. T. Quercetin potentiates UVB-induced c-Fos expression: Implications for its use as a chemopreventive agent. Cancer Prev. Res (Phila)., 2010, 3(7), 876-884.
95. Chien, S. Y.; Wu, Y. C.; Chung, J. G.; Yang, J. S.; Lu, H. F.; Tsou, M. F.; Wood, W.; Kuo, S. J.; Chen, D. R. Quercetin-induced apoptosis acts through mitochondrial-and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells. Hum. Exp. Toxicol., 2009, 28(8), 493-503.
96. Ranelletti, F. O.; Maggiano, N.; Serra, F. G.; Ricci, R.; Larocca, L. M.; Lanza, P.; Scambia, G.; Fattorossi, A.; Capelli, A.; Piantelli, M. Quercetin inhibits p21 RAS expression in human colon cancer cell lines and in primary colorectal tumors. Int. J. Cancer., 2000, 85(3), 438-445.
97. Casagrande, F.; Darbon, J. M. Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK11. Biochem. Pharmacol., 2001, 61(10), 1205-1215.
98. Spencer, J. P. E.; Rice-Evans, C.; Williams, R. J. Modulation of pro-survival Akt/PKB and ERK1/2 signalling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J. Biol. Chem., 2003, 278(37), 34783-34793.
99. Robaszkiewicz, A.; Balcerczyk, A.; Bartosz, G. Antioxidative and prooxidative effects of quercetin on A549 cells. Cell. Biol. Int., 2007, 31(10), 1245-1250.
100. Murota, K.; Terao, J. Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism* 1. Arch. Biochem. Biophys., 2003, 417(1), 12-17.
101. Murakami, A.; Ashida, H.; Terao, J. Multitargeted cancer prevention by quercetin. Cancer Lett., 2008, 269(2), 315-325.
102. Vijayababu, M.; Kanagaraj, P.; Arunkumar, A.; Ilangovan, R.; Aruldhas, M.; Arunakaran, J. Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression. J. Cancer Res. Clin. Oncol., 2005, 131(11), 765-771.
103. Ding, M.; Zhao, J.; Bowman, L.; Lu, Y.; Shi, X. Inhibition of AP-1 and MAPK signaling and activation of Nrf2/ARE pathway by quercitrin. Int. J. Oncol., 2010, 36(1), 59-67.
104. Wang, K.; Liu, R.; Li, J.; Mao, J.; Lei, Y.; Wu, J.; Zeng, J.; Zhang, T.; Wu, H.; Chen, L. Quercetin induces protective autophagy in gastric cancer cells: Involvement of Akt-mTOR-and hypoxia-induced factor 1 -mediated signaling. Autophagy. 2011, 7(9), 966-978.
105. Hansen, R.; Oesterreich, S.; Lemieux, P.; Sarge, K.; Fuqua, S. Quercetin inhibits heat shock protein induction but not heat shock factor DNA-binding in human breast carcinoma cells. Biochem. Biophys. Res. Commun., 1997, 239(3), 851-856.
106. Elia, G.; Amici, C.; Rossi, A.; Santoro, M. G. Modulation of prostaglandin A1-induced thermotolerance by quercetin in human leukemic cells: role of heat shock protein 70. Cancer Res., 1996, 56(1), 210-217.
107. Koishi, M.; Hosokawa, N.; Sato, M.; Nakai, A.; Hirayoshi, K.; Hiraoka, M.; Abe, M.; Nagata, K. Quercetin, an inhibitor of heat shock protein synthesis, inhibits the acquisition of thermotolerance in a human colon carcinoma cell line. Jpn. J. Cancer Res., 1992, 83(11), 1216-1222.
108. Singh, B.; Mense, S. M.; Bhat, N. K.; Putty, S.; Guthiel, W. A.; Remotti, F.; Bhat, H. K. Dietary quercetin exacerbates the development of estrogen-induced breast tumors in female ACI rats. Toxicol. Appl. Pharmacol., 2010, 247(2), 83-90.
109. Zhu, B.; Liehr, J. Quercetin increases the severity of estradiolinduced tumorigenesis in hamster kidney. Toxicol. Appl. Pharmacol., 1994, 125(1), 149-158.
110. Tachibana, H. Green tea polyphenol sensing. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci., 2011, 87(3), 66-80.
111. Higdon, J. V.; Frei, B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit. Rev. Food Sci. Nutr., 2003, 43(1), 89-143.
112. Shimizu, M.; Deguchi, A.; Lim, J. T. E.; Moriwaki, H.; Kopelovich, L.; Weinstein, I. B. (-)-Epigallocatechin Gallate and Polyphenon E Inhibit Growth and Activation of the Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor-2 Signaling Pathways in Human Colon Cancer Cells. Clin. Cancer Res., 2005, 11(7), 2735-2746.
113. Bose, M.; Hao, X.; Ju, J.; Husain, A.; Park, S.; Lambert, J. D.; Yang, C. S. Inhibition Of Tumorigenesis in Apc Min/+ Mice by a Combination of (-)-Epigallocatechin-3-gallate and Fish Oil. J. Agri. Food Chem., 2007, 55(19), 7695-7700.
114. Lu, Y. P.; Lou, Y. R.; Liao, J.; Xie, J. G.; Peng, Q. Y.; Yang, C. S.; Conney, A. H. Administration of green tea or caffeine enhances the disappearance of UVB-induced patches of mutant p53 positive epidermal cells in SKH-1 mice. Carcinogenesis., 2005, 26(8), 1465-1472.
115. Garbisa, S.; Biggin, S.; Cavallarin, N.; Sartor, L.; Benelli, R.; Albini, A. Tumor invasion: molecular shears blunted by green tea. Nat. Med., 1999, 5(11), 1216-1216.
116. Garbisa, S.; Sartor, L.; Biggin, S.; Salvato, B.; Benelli, R. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin 3 gallate. Cancer. 2001, 91(4), 822-832.
117. Annabi, B.; Lachambre, M. P.; Bousquet-Gagnon, N.; Pagé, M.; Gingras, D.; Béliveau, R. Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells. Biochim. Biophys. Acta., 2002, 1542(1-3), 209-220.
118. Stearns, M. E.; Wang, M. Synergistic Effects of the Green Tea Extract Epigallocatechin-3-gallate and Taxane in Eradication of Malignant Human Prostate Tumors. Transl. Oncol., 2011, 4(3), 147-156.
119. Zhu, B. H.; Chen, H. Y.; Zhan, W. H.; Wang, C. Y.; Cai, S. R.; Wang, Z.; Zhang, C. H.; He, Y. L. (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer. World J. Gastroenterol., 2011, 17(18), 2315-2325.
120. Ju, J.; Hong, J.; Zhou, J.; Pan, Z.; Bose, M.; Liao, J.; Yang, G.; Liu, Y. Y.; Hou, Z.; Lin, Y. Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res., 2005, 65(22), 10623-10631.
121. Shimizu, M.; Adachi, S.; Masuda, M.; Kozawa, O.; Moriwaki, H. Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases. Mol. Nutr. Food Res. 2011, 55(6), 832-43.
122. Onoda, C.; Kuribayashi, K.; Nirasawa, S.; Tsuji, N.; Tanaka, M.; Kobayashi, D.; Watanabe, N. -)-Epigallocatechin-3-gallate induces apoptosis in gastric cancer cell lines by down-regulating survivin expression. Int. J. Oncol., 2011, 38(5), 1403-8.
123. Tudoran, O.; Soritau, O.; Balacescu, O.; Balacescu, L.; Braicu, C.; Rus, M.; Gherman, C.; Virag, P.; Irimie, F.; Neagoe, I. B. Early transcriptional pattern of angiogenesis induced by EGCG treatment in cervical tumor cells. J. Cell. Mol. Med., 2011, 10, 1582-4934.
124. Vu, H.; Beppu, Y.; Chi, H.; Sasaki, K.; Yamamoto, H.; Xinh, P.; Tanii, T.; Hara, Y.; Watanabe, T.; Sato, Y., Ohdomari, I. Green tea epigalocatechin gallate exhibits anticancer effect in human pancreatic carcinoma cells via inhibition of both FAK and IGF-1R. J. Biomed. Biotechnol., 2010, 2010, 290516.
125. Van Aller, G. S.; Carson, J. D.; Tang, W.; Peng, H.; Zhao, L.; Copeland, R. A.; Tummino, P. J.; Luo, L. Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor. Biochem. Biophys. Res. Commun., 2011, 406(2), 194-199.
126. Xu, Q., Yang, C.H., Liu, Q., Jin, X.F., Xu, X.T., Tong, J.L., Xiao, S.D., Ran, Z.H. Chemopreventive effect of epigallocatechin-3-gallate (EGCG) and folic acid on the N-methyl-N'-nitro-Nnitrosoguanidine (MNNG)-induced gastrointestinal cancer in rat model. J. Dig. Dis., 2011, 12(3), 181-187.
127. Dong, Z.; Ma, W.; Huang, C.; Yang, C. S. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols,(-)-epigallocatechin gallate, and theaflavins. Cancer Res., 1997, 57(19), 4414-4419.
128. Koh, Y. W.; Choi, E. C.; Kang, S. U.; Hwang, H. S.; Lee, M. H.; Pyun, J. H.; Park, R. H.; Lee, Y. D.; Kim, C. H. Green tea (-)-epigallocatechin-3-gallate inhibits HGF-induced progression in oral cavity cancer through suppression of HGF/c-Met. J. Nutr. Biochem., 2011, 22(11), 1074-83.
129. Tanaka, T.; Ishii, T.; Mizuno, D.; Mori, T.; Yamaji, R.; Nakamura, Y.; Kumazawa, S.; Nakayama, T.; Akagawa, M. (-)-Epigallocatechin-3-gallate suppresses growth of AZ521 human gastric cancer cells by targeting the DEAD box RNA helicase p68. Free. Radic. Biol. Med., 2011, 50(10), 1324-35.
130. Lee, M. H.; Han, D. W.; Hyon, S. H.; Park, J. C. Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-B. Apoptosis. 2011, 16(1), 75-85.
131. Shankar, S.; Ganapathy, S.; Hingorani, S.; Srivastava, R. EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front Biosci., 2008, 13, 440-442.
132. Cavell, B. E.; Alwi, S. S. S.; Donlevy, A.; Packham, G. Antiangiogenic effects of dietary isothiocyanates; mechanisms of action and implications for human health. Biochem. Pharmacol., 2010, 81(3): 327-36.
133. Lam, T. K.; Gallicchio, L.; Lindsley, K.; Shiels, M.; Hammond, E.; Tao, X. G.; Chen, L.; Robinson, K. A.; Caulfield, L. E.; Herman, J. G. Cruciferous vegetable consumption and lung cancer risk: a systematic review. Cancer Epidemiol. Biomarkers Prev., 2009, 18(1), 184-195.
134. Mi, L.; Di Pasqua, A. J.; Chung, F. L. Proteins as Binding Targets of Isothiocyanates in Cancer Prevention. Carcinogenesis., 2011, 32(10), 1405-13.
135. Nakamura, Y. Chemoprevention by isothiocyanates: molecular basis of apoptosis induction. Forum Nutr., 2009, 61, 170-81.
136. Wu, X.; Zhou, Q.; Xu, K. Are isothiocyanates potential anti-cancer drugs? Acta Pharmacol. Sin., 2009, 30(5), 501-512.
137. Gong, A.; He, M.; Krishna Vanaja, D.; Yin, P.; Karnes, R. J.; Young, C. Y. F. Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells. Mol. Nutr. Food Res., 2009, 53(7), 878-886.
138. Kang, L.; Ding, L.; Wang, Z. Y. Isothiocyanates repress estrogen receptor expression in breast cancer cells. Oncol. Rep., 2009, 21(1), 185-192.
139. Mi, L.; Gan, N.; Cheema, A.; Dakshanamurthy, S.; Wang, X.; Yang, D. C. H.; Chung, F. L. Cancer preventive isothiocyanates induce selective degradation of cellular -and -tubulins by proteasomes. J. Biol.Chem., 2009, 284(25), 17039-17051.
140. Mukherjee, S.; Dey, S.; Bhattacharya, R.; Roy, M. Isothiocyanates sensitize the effect of chemotherapeutic drugs via modulation of protein kinase C and telomerase in cervical cancer cells. Mol. Cell. Biochem., 2009, 330(1), 9-22.
141. Xu, K.; Thornalley, P. Signal transduction activated by the cancer chemopreventive isothiocyanates: cleavage of BID protein, tyrosine phosphorylation and activation of JNK. Br. J. Cancer., 2001, 84(5), 670-673.
142. Prawan, A.; Saw, C. L. L.; Khor, T. O.; Keum, Y. S.; Yu, S.; Hu, L.; Kong, A. N. Anti-NF-[kappa] B and anti-inflammatory activities of synthetic isothiocyanates: Effect of chemical structures and cellular signaling. Chem. Biol. Interact., 2009, 179(2-3), 202-211.
143. Jakubikova, J.; Bao, Y.; Sedlak, J. Isothiocyanates induce cell cycle arrest, apoptosis and mitochondrial potential depolarization in HL-60 and multidrug-resistant cell lines. Anticancer Res., 2005, 25(5), 3375.
144. Cheung, K. L.; Kong, A. N. Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J., 2010, 12(1), 87-97.
145. Powolny, A. A.; Bommareddy, A.; Hahm, E. R.; Normolle, D. P.; Beumer, J. H.; Nelson, J. B.; Singh, S. V. Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer. J. Natl. Cancer Inst., 2011, 103(7), 571-584.
146. Huong, L.; Shim, J.; Choi, K.; Shin, J.; Choi, E.; Kim, H.; Lee, S.; Kim, S.; Cho, N.; Cho, S. Effect of -phenylethyl isothiocyanate from Cruciferous Vegetables on Growth Inhibition and Apoptosis of Cervical cancer cells through the Induction of Death Receptor 4 and 5. J. Agric. Food Chem., 2011, 59(15), 8124-31.
147. Tang, N. O. U. Y.; Huang, Y. A. T.; Yu, C. S. H. U.; Ko, Y. C.; Wu, S. H.; Ji, B. I. N. C.; Yang, J. A. I. S.; Yang, J. L.; Hsia, T. E. C.; Chen, Y. A. Y. I. N. Phenethyl Isothiocyanate (PEITC) Promotes G2/M Phase Arrest via p53 Expression and Induces Apoptosis through Caspase-and Mitochondria-dependent Signaling Pathways in Human Prostate Cancer DU 145 Cells. Anticancer Res., 2011, 31(5), 1691-1702.
148. Wu, C. L.; Huang, A. C.; Yang, J. S.; Liao, C. L.; Lu, H. F.; Chou, S. T.; Ma, C. Y.; Hsia, T. C.; Ko, Y. C.; Chung, J. G. Benzyl isothiocyanate (BITC) and phenethyl isothiocyanate (PEITC)-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of caspase-3, mitochondria dysfunction and nitric oxide (NO) in human osteogenic sarcoma U-2 OS cells. J. Orthop. Res., 2011, 29(8), 1199-1209.
149. Hwang, E. S.; Lee, H. J. Benzyl isothiocyanate inhibits metalloproteinase-2/-9 expression by suppressing the mitogenactivated protein kinase in SK-Hep1 human hepatoma cells. Food Chem. Toxicol., 2008, 46(7), 2358-2364.
150. Lai, K. C.; Huang, A. C.; Hsu, S. C.; Kuo, C. L.; Yang, J. S.; Wu, S. H.; Chung, J. G. Benzyl isothiocyanate (BITC) inhibits migration and invasion of human colon cancer HT29 cells by inhibiting matrix metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway. J. Agric. Food Chem., 2010, 58(5), 2935-2942.
151. Hunakova, L.; Sedlakova, O.; Cholujova, D.; Gronesova, P.; Duraj, J.; Sedlak, J.; Altanerova, V.; Horvathova, E.; Matuskova, M.; Kucerova, L. Modulation of markers associated with aggressive phenotype in MDA-MB-231 breast carcinoma cells by sulforaphane. Neoplasma., 2009, 56(5), 435-440.
152. Yan, H.; Zhu, Y.; Liu, B.; Wu, H.; Li, Y.; Wu, X.; Zhou, Q.; Xu, K. Mitogen-activated protein kinase mediates the apoptosis of highly metastatic human non-small cell lung cancer cells induced by isothiocyanates. Br. J. Nutr., 2011, 1(1), 1-13.
153. Yang, M. E. I. D. U. E.; Lai, K. C. H. I.; Lai, T. Y.; Hsu, S. H. U. C.; Kuo, C. L. I. N.; Yu, C. S. H. U.; Lin, M. L.; Yang, J. A. I. S.; Kuo, H.; Wu, S. H. Phenethyl Isothiocyanate Inhibits Migration and Invasion of Human Gastric Cancer AGS Cells through Suppressing MAPK and NF-B Signal Pathways. Anticancer Res., 2010, 30(6), 2135-2143.
154. Chen, N. G.; Chen, K. T.; Lu, C. C.; Lan, Y. H.; Lai, C. H.; Chung, Y. T.; Yang, J. S.; Lin, Y. C. Allyl isothiocyanate triggers G2/M phase arrest and apoptosis in human brain malignant glioma GBM 8401 cells through a mitochondria-dependent pathway. Oncol. Rep., 2010, 24(2), 449-455.
155. Shan, Y.; Zhao, R.; Geng, W.; Lin, N.; Wang, X.; Du, X.; Wang, S. Protective effect of sulforaphane on human vascular endothelial cells against lipopolysaccharide-induced inflammatory damage. Cardiovasc. Toxicol., 2010, 10(2), 139-145.
156. Hahm, E. R.; Singh, S. V. Sulforaphane Inhibits Constitutive and Interleukin-6-Induced Activation of Signal Transducer and Activator of Transcription 3 in Prostate Cancer Cells. Cancer Prev. Res (Phila)., 2010, 3(4), 484-494.
157. Ding, Y.; Paonessa, J. D.; Randall, K. L.; Argoti, D.; Chen, L.; Vouros, P.; Zhang, Y. Sulforaphane inhibits 4-aminobiphenylinduced DNA damage in bladder cells and tissues. Carcinogenesis., 2010, 31(11), 1999-2003.
158. Hamsa, T. P.; Thejass, P.; Kuttan, G. Induction of apoptosis by sulforaphane in highly metastatic B16F-10 melanoma cells. Drug Chem. Toxicol., 2011, 34(3), 332-340.
159. Zeng, H.; Trujillo, O.; Moyer, M.; Botnen, J. Prolonged Sulforaphane Treatment Activates Survival Signaling in Nontumorigenic NCM460 Colon Cells but Apoptotic Signaling in Tumorigenic HCT116 Colon Cells. Nutr. Cancer., 2011, 63(2), 248-255.
160. Park, S. Y.; Kim, G. I. Y.; Bae, S. J.; Yoo, Y. H.; Choi, Y. H. Induction of apoptosis by isothiocyanate sulforaphane in human cervical carcinoma HeLa and hepatocarcinoma HepG2 cells through activation of caspase-3. Oncol. Rep., 2007, 18(1), 181-187.
161. Fotsis, T.; Pepper, M.; Adlercreutz, H.; Hase, T.; Montesano, R.; Schweigerer, L. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J. Nutr., 1995, 125(3 Suppl), 790S-797S.
162. Li, W.; Frame, L. T.; Hirsch, S.; Cobos, E. Genistein and hematological malignancies. Cancer lett., 2010, 296(1), 1-8.
163. Barnes, S. Effect of genistein on in vitro and in vivo models of cancer. J. Nutr., 1995, 125(3 Suppl), 777S.
164. Lamartiniere, C. A.; Cotroneo, M. S.; Fritz, W. A.; Wang, J.; Mentor-Marcel, R.; Elgavish, A. Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J. Nutr., 2002, 132(3), 552S.
165. Qi, W.; Weber, C. R.; Wasland, K.; Savkovic, S. D. Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity. BMC Cancer., 2011, 11, 219. Epub 2011/06/07.
166. Fan, Y.; Li, G.; Wang, Y.; Ren, Q.; Shi, H. Effects of genistein on colon cancer cells in vitro and in vivo and its mechanism of action]. Zhonghua zhong liu za zhi [Chinese Journal of Oncology]. 2010, 32(1), 4.
167. Li, M.; Zhang, Z.; Hill, D. L.; Chen, X.; Wang, H.; Zhang, R. Genistein, a dietary isoflavone, down-regulates the MDM2 oncogene at both transcriptional and posttranslational levels. Cancer Res., 2005, 65(18), 8200.
168. Magee, P. J.; Rowland, I. R. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br. J. Nutr., 2004, 91(4), 513-532.
169. Fan, S.; Meng, Q.; Auborn, K.; Carter, T.; Rosen, E. BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br. J. Cancer., 2006, 94(3), 407-426.
170. Vissac-Sabatier, C.; Coxam, V.; Déchelotte, P.; Picherit, C.; Horcajada, M. N.; Davicco, M. J.; Lebecque, P.; Bignon, Y. J.; Bernard-Gallon, D. Phytoestrogen-rich diets modulate expression of Brca1 and Brca2 tumor suppressor genes in mammary glands of female Wistar rats. Cancer Res., 2003, 63(20), 6607.
171. El-Rayes, B. F.; Ali, S.; Ali, I. F.; Philip, P. A.; Abbruzzese, J.; Sarkar, F. H. Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-B. Cancer Res., 2006, 66(21), 10553.
172. Zhang, Y.; Chen, H. Genistein attenuates WNT signaling by upregulating sFRP2 in a human colon cancer cell line. Exp. Biol. Med., 2011, 236(6), 714.
173. Blanco, A.; Habib, A.; Levy-Toledano, S.; Maclouf, J. Involvement of tyrosine kinases in the induction of cyclo-oxygenase-2 in human endothelial cells. Biochem. J., 1995, 312(Pt 2), 419.
174. Lin, C. H.; Wu, C. H.; Thum, W. Y.; Ho, Y. S.; Lee, H. M. Involvement of p38 mitogen-activated protein kinase in PLL-AGEinduced cyclooxgenase-2 expression. Eur. J. Pharmacol., 2002, 438(3), 143-152.
175. Luo, S. F.; Wang, C. C.; Chien, C. S.; Hsiao, L. D.; Yang, C. M. Induction of cyclooxygenase-2 by lipopolysaccharide in canine tracheal smooth muscle cells: involvement of p42/p44 and p38 mitogen-activated protein kinases and nuclear factor-[kappa] B pathways. Cellular signalling. 2003, 15(5), 497-509.
176. Swami, S.; Krishnan, A. V.; Moreno, J.; Bhattacharyya, R. S.; Gardner, C.; Brooks, J. D.; Peehl, D. M.; Feldman, D. Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients. Int. J. Cancer., 2009, 124(9), 2050-2059.
177. Hillman, G. G.; Wang, Y.; Kucuk, O.; Che, M.; Doerge, D. R.; Yudelev, M.; Joiner, M. C.; Marples, B.; Forman, J. D.; Sarkar, F. H. Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model. Mol. Cancer Ther. 2004, 3(10), 1271.
178. Raffoul, J. J.; Banerjee, S.; Singh-Gupta, V.; Knoll, Z. E.; Fite, A.; Zhang, H.; Abrams, J.; Sarkar, F. H.; Hillman, G. G. Downregulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo. Cancer Res., 2007, 67(5), 2141.
179. Raffoul, J.; Wang, Y.; Kucuk, O.; Forman, J.; Sarkar, F.; Hillman, G. Genistein inhibits radiation-induced activation of NF-B in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer. 2006, 6(1), 107.
180. Yu, X.; Zhu, J.; Mi, M.; Chen, W.; Pan, Q.; Wei, M. Antiangiogenic genistein inhibits VEGF-induced endothelial cell activation by decreasing PTK activity and MAPK activation. Med. Oncol., 2010, 1-9.
181. Yatagai, C.; Singu, T.; Maruyama, M.; Sumi, H. Genistein and Its Analogue Enhanced Tissue Plasminogen Activator Activity in HeLa S3. Pathophysiol. Haemost Thromb., 2007, 36(6), 298-304.
182. Gadgeel, S. M.; Ali, S.; Philip, P. A.; Wozniak, A.; Sarkar, F. H. Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines. Cancer., 2009, 115(10), 2165-2176.
183. Valsecchi, A. E.; Franchi, S.; Panerai, A. E.; Rossi, A.; Sacerdote, P.; Colleoni, M. The soy isoflavone genistein reverses oxidative and inflammatory state, neuropathic pain, neurotrophic and vasculature deficits in diabetes mouse model. Eur. J. Pharmacol., 2010.
184. Lee, Y. K., Park, O.J. Soybean isoflavone genistein regulates apoptosis through NF-?B dependent and independent pathways. Exp. Toxicol. Pathol., 2011.
185. Singh Gupta, V.; Zhang, H.; Banerjee, S.; Kong, D.; Raffoul, J. J.; Sarkar, F. H.; Hillman, G. G. Radiation induced HIF 1 cell survival pathway is inhibited by soy isoflavones in prostate cancer cells. Int. J. Cancer., 2009, 124(7), 1675-1684.
186. Wang, Y. J.; Lu, J.; Wu, D.; Zheng, Z.; Zheng, Y. L.; Wang, X.; Ruan, J.; Sun, X.; Shan, Q.; Zhang, Z. Ursolic acid attenuates lipopolysaccharide-induced cognitive deficits in mouse brain through suppressing p38/NF-[kappa] B mediated inflammatory pathways. Neurobiol. Learn. Mem., 2011, 96(2), 156-65.
187. Mizushina, Y.; Iida, A.; Ohta, K.; Sugawara, F.; Sakaguchi, K. Novel triterpenoids inhibit both DNA polymerase and DNA topoisomerase. Biochem. J., 2000, 3, 757-63.
188. Gayathri, R.; Priya, D.; Gunassekaran, G.; Sakthisekaran, D. Ursolic acid attenuates oxidative stress-mediated hepatocellular carcinoma induction by diethylnitrosamine in male Wistar rats. Asian Pac. J. Cancer Prev., 2009, 10(5), 933-938.
189. Subbaramaiah, K.; Michaluart, P.; Sporn, M. B.; Dannenberg, A. J. Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Cancer Res., 2000, 60(9), 2399-2404.
190. Shanmugam, M. K.; Rajendran, P.; Li, F.; Nema, T.; Vali, S.; Abbasi, T.; Kapoor, S.; Sharma, A.; Kumar, A. P.; Ho, P. C.; Hui, K. M.; Sethi, G. Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice. J. Mol. Med (Berl)., 2011, 89(7), 713-727.
191. Harmand, P. O., Duval, R., Liagre, B., Jayat-Vignoles, C., Beneytout, J.L., Delage, C., Simon, A. Ursolic acid induces apoptosis through caspase-3 activation and cell cycle arrest in HaCat cells. Int. J. Oncol., 2003, 23(1), 105-112.
192. Wang, J.; Ren, T.; Xi, T. Ursolic acid induces apoptosis by suppressing the expression of FoxM1 in MCF-7 human breast cancer cells. Med. Oncol., 2010, 1-6.
193. Prasad, S.; Yadav, V. R.; Kannappan, R.; Aggarwal, B. B. Ursolic Acid, a Pentacyclin Triterpene, Potentiates TRAIL-induced Apoptosis through p53-independent Up-regulation of Death Receptors. J. Biol. Chem., 2011, 286(7), 5546-5557.
194. Manu, K.; Kuttan, G. Ursolic acid induces apoptosis by activating p53 and caspase-3 gene expressions and suppressing NF-[kappa] B mediated activation of bcl-2 in B16F-10 melanoma cells. Int. Immunopharmacol., 2008, 8(7), 974-981.
195. Yu, L. B.; Wang, J.; Ma, B. Z.; Sun, W. Z. [Inhibitive effect of ursolic acid on the invasion and metastasis of ovarian carcinoma cells HO-8910PM]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010, 41(6), 986-988, 1038.
196. Shanmugam, M. K.; Manu, K. A.; Ong, T. H.; Ramachandran, L.; Surana, R.; Bist, P.; Lim, L. H. K.; Kumar, A. P.; Hui, K. M.; Sethi, G. Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model. Int. J. Cancer., 2011, 129(7), 1552-63.
197. Zhang, Y.; Kong, C.; Zeng, Y.; Wang, L.; Li, Z.; Wang, H.; Xu, C.; Sun, Y. Ursolic acid induces PC 3 cell apoptosis via activation of JNK and inhibition of Akt pathways in vitro. Mol. Carcinog., 2010, 49(4), 374-385.
198. Yeh, C. T.; Wu, C. H.; Yen, G. C. Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c Jun N terminal kinase, Akt and mammalian target of rapamycin signaling. Mol. Nutr. Food Res., 2010, 54(9), 1285-1295.
199. Kanjoormana, M.; Kuttan, G. Antiangiogenic activity of ursolic acid. Integr. Cancer Ther., 2010, 9(2), 224-235.
200. Cárdenas, C.; Quesada, A. R.; Medina, M. Á. Effects of ursolic acid on different steps of the angiogenic process. Biochem. Biophys. Res. Commun., 2004, 320(2), 402-408.
201. Raphael, T.; Kuttan, G. Effect of naturally occurring triterpenoids ursolic acid and glycyrrhizic acid on the cell-mediated immune responses of metastatic tumor-bearing animals. Immunopharmacol. Immunotoxicol., 2008, 30(2), 243-255.
202. Rahman, M. A.; Amin, A. R.; Shin, D. M. Chemopreventive potential of natural compounds in head and neck cancer. Nutr. Cancer. 2010, 62(7), 973-987.
203. Krinsky, N. I. The Antioxidant and Biological Properties of the Carotenoidsa. Ann N Y Acad Sci.,1998, 854(1), 443-447.
204. Obermüller-Jevic, U. C.; Olano-Martin, E.; Corbacho, A. M.; Eiserich, J. P.; van der Vliet, A.; Valacchi, G.; Cross, C. E.; Packer, L. Lycopene inhibits the growth of normal human prostate epithelial cells in vitro. J. Nutr., 2003, 133(11), 3356-3360.
205. Levy, J.; Bosin, E.; Feldman, B.; Giat, Y.; Miinster, A.; Danilenko, M.; Sharoni, Y. Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene. Nutr. Cancer., 1995, 24(3), 257-266.
206. Salman, H.; Bergman, M.; Djaldetti, M.; Bessler, H. Lycopene affects proliferation and apoptosis of four malignant cell lines. Biomed. Pharmacother., 2007, 61(6), 366-369.
207. Amir, H.; Karas, M.; Giat, J.; Danilenko, M.; Levy, R.; Yermiahu, T.; Levy, J.; Sharoni, Y. Lycopene and 1, 25-dihydroxyvitamin D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells. Nutr. Cancer., 1999, 33(1), 105-112.
208. Hwang, E. S.; Lee, H. J. Inhibitory effects of lycopene on the adhesion, invasion, and migration of SK-Hep1 human hepatoma cells. Exp. Biol. Med., 2006, 231(3), 322-327.
209. Nahum, A.; Hirsch, K.; Danilenko, M.; Watts, C.; Prall, O.; Levy, J.; Sharoni, Y. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27 (Kip1) in the cyclin E-cdk2 complexes. Oncogene., 2001, 20(26), 3428-3436.
210. Nahum, A.; Zeller, L.; Danilenko, M.; Prall, O. W. J.; Watts, C. K. W.; Sutherland, R. L.; Levy, J.; Sharoni, Y. Lycopene inhibition of IGF-induced cancer cell growth depends on the level of cyclin D1. Eur. J. Nutr., 2006, 45(5), 275-282.
211. Siler, U.; Barella, L.; Spitzer, V.; Schnorr, J.; Lein, M.; Goralczyk, R.; Wertz, K. Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model. FASEB J., 2004, 18(9), 1019-1021.
212. Kucuk, O.; Sarkar, F. H.; Sakr, W.; Djuric, Z.; Pollak, M. N.; Khachik, F.; Li, Y. W.; Banerjee, M.; Grignon, D.; Bertram, J. S. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol. Biomarkers Prev., 2001, 10(8), 861-868.
213. Vaishampayan, U.; Hussain, M.; Banerjee, M.; Seren, S.; Sarkar, F. H.; Fontana, J.; Forman, J. D.; Cher, M. L.; Powell, I.; Pontes, J. E. Lycopene and soy isoflavones in the treatment of prostate cancer. Nutr. Cancer., 2007, 59(1), 1-7.
214. Chalabi, N.; Satih, S.; Delort, L.; Bignon, Y. J.; Bernard-Gallon, D. J. Expression profiling by whole-genome microarray hybridization reveals differential gene expression in breast cancer cell lines after lycopene exposure. Biochim. Biophys. Acta., 2007, 1769(2), 124-130.
215. Palozza, P.; Colangelo, M.; Simone, R.; Catalano, A.; Boninsegna, A.; Lanza, P.; Monego, G.; Ranelletti, F. O. Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines. Carcinogenesis. 2010, 31(10), 1813-1821.
216. Scolastici, C.; Alves de Lima, R.; Barbisan, L.; Ferreira, A.; Ribeiro, D.; Salvadori, D. Antigenotoxicity and antimutagenicity of lycopene in HepG2 cell line evaluated by the comet assay and micronucleus test. Toxicol. In Vitro., 2008, 22(2), 510-514.
217. Kelkel, M.; Schumacher, M.; Dicato, M.; Diederich, M. Antioxidant and anti-proliferative properties of lycopene. Free Radic. Res., 2011, (0), 1-16.
218. Stark, M. J.; Burke, Y. D.; McKinzie, J. H.; Ayoubi, A. S.; Crowell, P. L. Chemotherapy of pancreatic cancer with the monoterpene perillyl alcohol. Cancer lett., 1995, 96(1), 15-21.
219. Mills, J. J.; Chari, R. S.; Boyer, I. J.; Gould, M. N.; Jirtle, R. L. Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol. Cancer Res., 1995, 55(5), 979-983.
220. Crowell, P. L.; Ren, Z.; Lin, S.; Vedejs, E.; Gould, M. N. Structureactivity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation. Biochem. Pharmacol., 1994, 47(8), 1405-1415.
221. Haag, J. D.; Gould, M. N. Mammary carcinoma regression induced by perillyl alcohol, a hydroxylated analog of limonene. Cancer Chemother. Pharmacol., 1994, 34(6), 477-483.
222. Elegbede, J.; Elson, C.; Tanner, M.; Qureshi, A.; Gould, M. Regression of rat primary mammary tumors following dietary dlimonene. J. Natl. Cancer Inst.,1986, 76(2), 323-325.
223. Haag, J. D.; Lindstrom, M. J.; Gould, M. N. Limonene-induced regression of mammary carcinomas. Cancer Res., 1992, 52(14), 4021-4026.
224. Chaudhary, S. C.; Alam, M. S.; Siddiqui, M.; Athar, M. Perillyl alcohol attenuates Ras-ERK signaling to inhibit murine skin inflammation and tumorigenesis. Chem. Biol. Interact., 2009, 179(2-3), 145-153.
225. Elegbede, J. A.; Flores, R.; Wang, R. C. Perillyl alcohol and perillaldehyde induced cell cycle arrest and cell death in BroTo and A549 cells cultured in vitro. Life Sci., 2003, 73(22), 2831-2840.
226. Xu, M.; Floyd, H. S.; Greth, S. M.; Chang, W. C. L.; Lohman, K.; Stoyanova, R.; Kucera, G. L.; Kute, T. E.; Willingham, M. C.; Miller, M. S. Perillyl alcohol-mediated inhibition of lung cancer cell line proliferation: potential mechanisms for its chemotherapeutic effects. Toxicol. Appl. Pharmacol., 2004, 195(2), 232-246.
227. Bardon, S.; Foussard, V.; Fournel, S.; Loubat, A. Monoterpenes inhibit proliferation of human colon cancer cells by modulating cell cycle-related protein expression. Cancer Lett., 2002, 181(2), 187-194.
228. Yeruva, L.; Hall, C.; Elegbede, J. A.; Carper, S. W. Perillyl alcohol and methyl jasmonate sensitize cancer cells to cisplatin. Anticancer Drugs., 2010, 21(1), 1-9.
229. Yeruva, L.; Pierre, K. J.; Elegbede, A.; Wang, R. C.; Carper, S. W. Perillyl alcohol and perillic acid induced cell cycle arrest and apoptosis in non small cell lung cancer cells. Cancer Lett., 2007, 257(2), 216-226.
230. Ura Ková, Z. Some current insights into oxidative stress. Physiol. Res., 2010, 59, 459-469.
231. Lee, K. W.; Lee, H. J. Biphasic effects of dietary antioxidants on oxidative stress-mediated carcinogenesis. Mech. Ageing Dev., 2006, 127(5), 424-431.
232. Cerutti, P. A. Prooxidant states and tumor promotion. Science. 1985, 227(4685), 375-381.
233. Konturek, P. C.; Kania, J.; Konturek, J. W.; Nikiforuk, A.; Konturek, S. J.; Hahn, E. G. H. pylori infection, atrophic gastritis, cytokines, gastrin, COX-2, PPAR gamma and impaired apoptosis in gastric carcinogenesis. Med. Sci. Monit., 2003, 9(7), SR53-SR66.
234. Nishigori, C.; Hattori, Y.; Toyokuni, S. Role of reactive oxygen species in skin carcinogenesis. Antioxid. Redox Signal., 2004, 6(3), 561-570.
235. Doll, R. An overview of the epidemiological evidence linking diet and cancer. Proc. Nutr. Soc., 1990, 49(02), 119-131.
236. Doll, R.; Peto, R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst., 1981, 66(6), 1191-1308.
237. La Vecchia, C.; Altieri, A.; Tavani, A. Vegetables, fruit, antioxidants and cancer: a review of Italian studies. Eur. J. Nutr., 2001, 40(6), 261-267.
238. Tardif, J. C. Antioxidants: the good, the bad and the ugly. Can. J. Cardiol., 2006, 22(Suppl B), 61B-65B.
239. Trosko, J. E.; Chang, C. C. Modulation of cell cell communication in the cause and chemoprevention/ chemotherapy of cancer. Biofactors. 2000, 12(1 4), 259-263.
240. Joe, B.; Vijaykumar, M.; Lokesh, B. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit. Rev. Food Sci. Nutr., 2004, 44(2), 97-111.
241. Motterlini, R.; Foresti, R.; Bassi, R.; Green, C. J. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic. Biol. Med., 2000, 28(8), 1303-1312.
242. Wright, J. S. Predicting the antioxidant activity of curcumin and curcuminoids. J. Mol. Struct., 2002, 591(1-3), 207-217.
243. Iqbal, M.; Sharma, S. D.; Okazaki, Y.; Fujisawa, M.; Okada, S. Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: possible role in protection against chemical carcinogenesis and toxicity. Pharmacol. Toxicol., 2003, 92(1), 33-38.
244. Song, E. K.; Cho, H.; Kim, J. S.; Kim, N. Y.; An, N. H.; Kim, J. A.; Lee, S. H.; Kim, Y. C. Diarylheptanoids with free radical scavenging and hepatoprotective activity in vitro from Curcuma longa. Planta Med., 2001, 67(9), 876-877.
245. Farghaly, H. S., Hussein, M.A. Protective Effect of Curcumin Against Paracetamol-induced Liver Damage. Aust. J. Bas. Appl. Sci., 2010, 4(9), 4266-4274.
246. Pan, M. H.; Lin-Shiau, S. Y.; Lin, J. K. Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of I [kappa] B kinase and NF [kappa] B activation in macrophages. Biochem. Pharmacol., 2000, 60(11), 1665-1676.
247. Brouet, I.; Ohshima, H. Curcumin, an anti-tumor promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem. Biophys. Res. Commun., 1995, 206(2), 533-540.
248. Palsamy, P.; Sivakumar, S.; Subramanian, S. Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocinnicotinamide-induced experimental diabetic rats. Chem. Biol. Interact., 2010, 186(2), 200-210.
249. Pintea, A.; Rugin, D.; Pop, R.; Bunea, A.; Socaciu, C.; Diehl, H. A. Antioxidant Effect of Trans-Resveratrol in Cultured Human Retinal Pigment Epithelial Cells. J. Ocul. Pharmacol. Ther., 2011, 27(4), 315-21.
250. Spanier, G.; Xu, H.; Xia, N.; Tobias, S.; Deng, S.; Wojnowski, L.; Forstermann, U.; Li, H. Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). J. Physiol. Pharmacol., 2009, 60(Suppl 4), 111-116.
251. Valcic, S.; Muders, A.; Jacobsen, N. E.; Liebler, D. C.; Timmermann, B. N. Antioxidant chemistry of green tea catechins. Identification of products of the reaction of (-)-epigallocatechin gallate with peroxyl radicals. Chem. Res. Toxicol., 1999, 12(4), 382-386.
252. Levites, Y.; Amit, T.; Mandel, S.; Youdim, M. B. Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate. FASEB J. 2003, 17(8), 952-954.
253. Bastianetto, S.; Yao, Z. X.; Papadopoulos, V.; Quirion, R. Neuroprotective effects of green and black teas and their catechin gallate esters against amyloid induced toxicity. Eur. J. Neurosci., 2006, 23(1), 55-64.
254. Senthil Kumaran, V.; Arulmathi, K.; Srividhya, R.; Kalaiselvi, P. Repletion of antioxidant status by EGCG and retardation of oxidative damage induced macromolecular anomalies in aged rats. Exp. Gerontol., 2008, 43(3), 176-183.
255. Raza, H.; John, A. Green tea polyphenol epigallocatechin-3-gallate differentially modulates oxidative stress in PC12 cell compartments. Toxicol. Appl. Pharmacol., 2005, 207(3), 212-220.
256. Prince Vijeya Singh, J.; Selvendiran, K.; Mumtaz Banu, S.; Padmavathi, R.; Sakthisekaran, D. Protective role of Apigenin on the status of lipid peroxidation and antioxidant defense against hepatocarcinogenesis in Wistar albino rats. Phytomedicine. 2004, 11(4), 309-314.
257. Saravanan, R.; Pugalendi, V. Impact of ursolic acid on chronic ethanol-induced oxidative stress in the rat heart. Pharmacol. Rep., 2006, 58(1), 41.
258. Saravanan, R.; Viswanathan, P.; Pugalendi, K. V. Protective effect of ursolic acid on ethanol-mediated experimental liver damage in rats. Life Sci., 2006, 78(7), 713-718.
259. Rao, A. V.; Agarwal, S. Role of antioxidant lycopene in cancer and heart disease. J. Am. Coll. Nutr., 2000, 19(5), 563-569.
260. Di Mascio, P.; Kaiser, S.; Sies, H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher* 1. Arch. Biochem. Biophys., 1989, 274(2), 532-538.
261. Böhm, F.; Tinkler, J.; Truscott, T. Carotenoids protect against cell membrane damage by the nitrogen dioxide radical. Nat. Med., 1995, 1(2), 98-99.
262. Lu, Y.; Etoh, H.; Watanabe, N.; Ina, K.; Ukai, N.; Oshima, S.; Ojima, F.; Sakamoto, H.; Ishiguro, Y. A new carotenoid, hydrogen peroxide oxidation products from lycopene. Bioscience, biotech. biochem., 1995, 59(11), 2153-2155.
263. Jain, C. K.; Agarwal, S.; Rao, A. V. The effect of dietary lycopene on bioavailability, tissue distribution, in vivo antioxidant properties and colonic preneoplasia in rats. Nutr. Res., 1999, 19(9), 1383-1391.
264. Tinkler, J. H.; Böhm, F.; Schalch, W.; Truscott, T. G. Dietary carotenoids protect human cells from damage. J. Photochem. Photobiol. B., 1994, 26(3), 283-285.
265. Chaturvedi, M.; Sung, B.; Yadav, V.; Kannappan, R.; Aggarwal, B. NF-B addiction and its role in cancer:'one size does not fit all'. Oncogene., 2010, 30(14), 1615-1630.
266. Chen, F. E.; Ghosh, G.: structural views. Oncogene., 1999, 18(49), 6845-6852.
267. Pahl, H. L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene., 1999, 18(49), 6853-6866.
268. Karin, M. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene., 1999, 18(49), 6867-6874.
269. Rayet, B.; Gelinas, C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene., 1999, 18(49), 6938-6947.
270. Nakshatri, H.; Bhat-Nakshatri, P.; Martin, D. A.; Goulet Jr, R. J.; Sledge Jr, G. W. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol. Cell Biol., 1997, 17(7), 3629-3639.
271. Bours, V.; Dejardin, E.; Goujon-Letawe, F.; Merville, M. P.; Castronovo, V. The NF-[kappa] B transcription factor and cancer: high expression of NF-[kappa] B-and I [kappa] B-related proteins in tumor cell lines. Biochem. Pharmacol., 1994, 47(1), 145-149.
272. Dejardin, E.; Deregowski, V.; Chapelier, M.; Jacobs, N.; Gielen, J.; Merville, M. P.; Bours, V. Regulation of NF-kappaB activity by I kappaB-related proteins in adenocarcinoma cells. Oncogene., 1999, 18(16), 2567-2577.
273. Wang, W.; Abbruzzese, J. L.; Evans, D. B.; Larry, L.; Cleary, K. R.; Chiao, P. J. The nuclear factor-B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin. Cancer Res., 1999, 5(1), 119-127.
274. Visconti, R.; Cerutti, J.; Battista, S.; Fedele, M.; Trapasso, F.; Zeki, K.; Miano, M. P.; de Nigris, F.; Casalino, L.; Curcio, F. Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression. Oncogene., 1997, 15(16), 1987-1994.
275. Sumitomo, M.; Tachibana, M.; Murai, M.; Hayakawa, M.; Nakamura, H.; Shimizu, N.; Ozu, C.; Asakura, H.; Takayanagi, A. Induction of apoptosis of cytokine-producing bladder cancer cells by adenovirus-mediated I kappa B alpha overexpression. Hum. Gene Ther., 1999, 10(1), 37-48.
276. Herrmann, J. L.; Beham, A. W.; Sarkiss, M.; Chiao, P. J.; Rands, M. T.; Bruckheimer, E. M.; Brisbay, S.; McDonnell, T. J. Bcl-2 Suppresses Apoptosis Resulting from Disruption of the NF-[kappa] B Survival Pathway. Exp. Cell. Res., 1997, 237(1), 101-109.
277. Devalaraja, M. N.; Wang, D. Z.; Ballard, D. W.; Richmond, A. Tumor Biology-Elevated Constitutive IkB Kinase Activity and IkB-a Phosphorylation in Hs294T Melanoma Cells Lead to Increased Basal MGSA/GRO-a Transcription. Cancer Research-Paper Edition. 1999, 59(6), 1372-1377.
278. Helbig, G.; Christopherson, K. W.; Bhat-Nakshatri, P.; Kumar, S.; Kishimoto, H.; Miller, K. D.; Broxmeyer, H. E.; Nakshatri, H. NFB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J. Biol. Chem., 2003, 278(24), 21631.
279. Coope, H.; Atkinson, P.; Huhse, B.; Belich, M.; Janzen, J.; Holman, M.; Klaus, G.; Johnston, L.; Ley, S. CD40 regulates the processing of NF-B2 p100 to p52. EMBO J., 2002, 21(20), 5375-5385.
280. Ghosh, S.; May, M. J.; Kopp, E. B. NF-B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol., 1998, 16(1), 225-260.
281. Siebenlist, U.; Franzoso, G.; Brown, K. Structure, regulation and function of NF-kappa B. Annu. Rev. Cell Biol., 1994, 10, 405-455.
282. Uzzo, R. G.; Clark, P. E.; Rayman, P.; Bloom, T.; Rybicki, L.; Novick, A. C.; Bukowski, R. M.; Finke, J. H. Alterations in NF B activation in T lymphocytes of patients with renal cell carcinoma. J. Natl. Cancer Inst., 1999, 91(8), 718.
283. Hoffmann, A.; Xia, Y.; Verma, I. M. Inflammatory tales of liver cancer. Cancer Cell., 2007, 11(2), 99-101.
284. Pari, L.; Tewas, D.; Eckel, J. Role of curcumin in health and disease. Arch. Physiol. Biochem., 2008, 114(2), 127-149.
285. Kozuch, P. L.; Hanauer, S. B. Treatment of inflammatory bowel disease: a review of medical therapy. World J. Gastroenterol., 2008, 14(3), 354-377.
286. Billerey Larmonier, C.; Uno, J. K.; Larmonier, N.; Midura, A. J.; Timmermann, B.; Ghishan, F. K.; Kiela, P. R. Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent. Inflamm. Bowel Dis., 2008, 14(6), 780-793.
287. Divya, C. S.; Pillai, M. R. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP 1 translocation, and modulation of apoptosis. Mol. Carcinog., 2006, 45(5), 320-332.
288. Singh, S.; Khar, A. Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anticancer Agents Med. Chem., 2006, 6(3), 259-270.
289. Shishodia, S.; Amin, H. M.; Lai, R.; Aggarwal, B. B. Curcumin (diferuloylmethane) inhibits constitutive NF-[kappa] B activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem. Pharmacol., 2005, 70(5), 700-713.
290. Collett, G. P.; Campbell, F. C. Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells. Carcinogenesis., 2004, 25(11), 2183-2189.
291. Sharma, C.; Kaur, J.; Shishodia, S.; Aggarwal, B. B.; Ralhan, R. Curcumin down regulates smokeless tobacco-induced NF-[kappa] B activation and COX-2 expression in human oral premalignant and cancer cells. Toxicology., 2006, 228(1), 1-15.
292. Alaikov, T.; Konstantinov, S. M.; Tzanova, T.; Dinev, K.; Topashika Ancheva, M.; Berger, M. R. Antineoplastic and anticlastogenic properties of curcumin. Ann. N. Y. Acad. Sci., 2007, 1095(1), 355-370.
293. Bachmeier, B. E.; Nerlich, A. G.; Iancu, C. M.; Cilli, M.; Schleicher, E.; Vené, R.; Dell'Eva, R.; Jochum, M.; Albini, A.; Pfeffer, U. The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol. Biochem., 2010, 19(1-4), 137-152.
294. Lin, Y. G.; Kunnumakkara, A. B.; Nair, A.; Merritt, W. M.; Han, L. Y.; Armaiz-Pena, G. N.; Kamat, A. A.; Spannuth, W. A.; Gershenson, D. M.; Lutgendorf, S. K. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-B pathway. Clin. Cancer Res., 2007, 13(11), 3423-3430.
295. Kunnumakkara, A. B.; Guha, S.; Krishnan, S.; Diagaradjane, P.; Gelovani, J.; Aggarwal, B. B. Curcumin Potentiates Antitumor Activity of Gemcitabine in an Orthotopic Model of Pancreatic Cancer through Suppression of Proliferation, Angiogenesis, and Inhibition of Nuclear Factor-B-Regulated Gene Products. Cancer Res., 2007, 67(8), 3853-3861.
296. Kamat, A. M.; Sethi, G.; Aggarwal, B. B. Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-B and nuclear factor-B- regulated gene products in IFN-sensitive and IFN-resistant human bladder cancer cells. Mol. Cancer Ther., 2007, 6(3), 1022-1030.
297. Deeb, D.; Jiang, H.; Gao, X.; Hafner, M. S.; Wong, H.; Divine, G.; Chapman, R. A.; Dulchavsky, S. A.; Gautam, S. C. Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-B through suppression of I B phosphorylation. Mol. Cancer Ther., 2004, 3(7), 803-812.
298. Khanbolooki, S.; Nawrocki, S. T.; Arumugam, T.; Andtbacka, R.; Pino, M. S.; Kurzrock, R.; Logsdon, C. D.; Abbruzzese, J. L.; McConkey, D. J. Nuclear factor-B maintains TRAIL resistance in human pancreatic cancer cells. Mol. Cancer Ther., 2006, 5(9), 2251-2260.
299. Manna, S. K.; Mukhopadhyay, A.; Aggarwal, B. B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol., 2000, 164(12), 6509-6519.
300. Kundu, J. K.; Shin, Y. K.; Kim, S. H.; Surh, Y. J. Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-B in mouse skin by blocking I B kinase activity. Carcinogenesis, 2006, 27(7), 1465-1474.
301. Nicholas, C.; Batra, S.; Vargo, M. A.; Voss, O. H.; Gavrilin, M. A.; Wewers, M. D.; Guttridge, D. C.; Grotewold, E.; Doseff, A. I. Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-B through the suppression of p65 phosphorylation. J. Immunol., 2007, 179(10), 7121-7127.
302. Xu, L.; Zhang, L.; Bertucci, A. M.; Pope, R. M.; Datta, S. K. Apigenin, a dietary flavonoid, sensitizes human T cells for activation-induced cell death by inhibiting PKB/Akt and NF-[kappa] B activation pathway. Immunol. Lett., 2008, 121(1), 74-83.
303. Shukla, S.; Gupta, S. Apigenin inhibits constitutive and TNFalphamediated NF-kappaB activation and induces apoptosis in human prostate carcinoma PC-3 cells: Correlation with NF-kappaB responsive genes. P. Am. Assoc. Cancer Res., 2004, 2004(1), 516.
304. Afaq, F.; Adhami, V. M.; Ahmad, N.; Mukhtar, H. Inhibition of ultraviolet B-mediated activation of nuclear factor B in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3-gallate. Oncogene., 2003, 22(7), 1035-1044.
305. Syed, D.; Afaq, F.; Kweon, M.; Hadi, N.; Bhatia, N.; Spiegelman, V.; Mukhtar, H. Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-B activation in normal human bronchial epithelial cells. Oncogene., 2006, 26(5), 673-682.
306. Bharrhan, S.; Chopra, K.; Arora, S. K.; Toor, J. S.; Rishi, P. Downregulation of NF-{kappa}B signalling by polyphenolic compounds prevents endotoxin-induced liver injury in a rat model. Innate Immun., 2011. Epub 2011/01/18.
307. Musonda, C. A.; Chipman, J. K. Quercetin inhibits hydrogen peroxide (H2O2)-induced NF-kappaB DNA binding activity and DNA damage in HepG2 cells. Carcinogenesis., 1998, 19(9), 1583-1589.
308. Davis, J. N.; Kucuk, O.; Sarkar, F. H. Genistein inhibits NF-kappa B activation in prostate cancer cells. Nutr. Cancer., 1999, 35(2), 167-174.
309. Li, Y.; Xing, D.; Chen, Q.; Chen, W. R. Enhancement of chemotherapeutic agent-induced apoptosis by inhibition of NFkappaB using ursolic acid. Int. J. Cancer., 2010, 127(2), 462-473.
310. Kuttan, G.; Pratheeshkumar, P. Invasion and Metastasis:Major Obstacles to Curative Cancer Therapy. In: Klein SA, Beckler JP, editors. In: Metastatic Melanoma: Symptoms, Diagnoses and Treatments: Nova Science Publishers, Inc.; 2011. p. 1-27.
311. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 1990, 82(1), 4-6.
312. McMahon, G. VEGF receptor signaling in tumor angiogenesis. Oncologist., 2000, 5(Supplement 1), 3-10.
313. Neal, C. P.; Berry, D. P. Basic principles of the molecular biology of cancer II: angiogenesis, invasion and metastasis. Surgery (Oxford). 2006, 24(4), 120-125.
314. Ellis, L.; Fidler, I. Angiogenesis and metastasis. Eur. J. Cancer., 1996, 32(14), 2451-2460.
315. Mekkawy, A. H.; Morris, D. L.; Pourgholami, M. H. Urokinase plasminogen activator system as a potential target for cancer therapy. Future Oncol., 2009, 5(9), 1487-1499.
316. Kessenbrock, K.; Plaks, V.; Werb, Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell., 2010, 141(1), 52-67.
317. Davidson, B.; Goldberg, I.; Gotlieb, W. H.; Kopolovic, J.; Risberg, B.; Ben-Baruch, G.; Reich, R. Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: A possible activation pathway? Cancer Metastasis Rev., 2003, 22(1), 103-115.
318. Varinska, L.; Mirossay, L.; Mojzisova, G.; Mojzis, J. Antiangogenic effect of selected phytochemicals. Pharmazie., 2010, 65(1), 57-63.
319. Bhandarkar, S. S.; Arbiser, J. L. Curcumin as an inhibitor of angiogenesis. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. 2007, 185-195.
320. Gururaj, A. E.; Belakavadi, M.; Venkatesh, D. A.; Marmé, D.; Salimath, B. P. Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem. Biophys. Res. Commun., 2002, 297(4), 934-942.
321. Mohan, R.; Sivak, J.; Ashton, P.; Russo, L. A.; Pham, B. Q.; Kasahara, N.; Raizman, M. B.; Fini, M. E. Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J. Biol. Chem., 2000, 275(14), 10405-10412.
322. Bae, M. K.; Kim, S. H.; Jeong, J. W. Curcumin inhibits hypoxiainduced angiogenesis via down-regulation of HIF-1. Oncol. Rep., 2006, 15(6), 1557-1562.
323. Thaloor, D.; Singh, A. K.; Sidhu, G. S.; Prasad, P. V.; Kleinman, H. K.; Maheshwari, R. K. Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. Cell Growth Differ., 1998, 9(4), 305-312.
324. Singh, A. K.; Seth, P.; Anthony, P.; Husain, M. M.; Madhavan, S.; Mukhtar, H.; Maheshwari, R. K. Green tea constituent epigallocatechin-3-gallate inhibits angiogenic differentiation of human endothelial cells. Arch. Biochem. Biophys., 2002, 401(1), 29-37.
325. Fang, J.; Zhou, Q.; Liu, L. Z.; Xia, C.; Hu, X.; Shi, X.; Jiang, B. H. Apigenin inhibits tumor angiogenesis through decreasing HIF-1 and VEGF expression. Carcinogenesis., 2006, 28(4), 858-864.
326. Osada, M.; Imaoka, S.; Funae, Y. Apigenin suppresses the expression of VEGF, an important factor for angiogenesis, in endothelial cells via degradation of HIF-1 [alpha] protein. FEBS Lett., 2004, 575(1-3), 59-63.
327. Su, S. J.; Yeh, T. M.; Chuang, W. J.; Ho, C. L.; Chang, K. L.; Cheng, H. L.; Liu, H. S.; Hsu, P. Y.; Chow, N. H. The novel targets for anti-angiogenesis of genistein on human cancer cells. Biochem. Pharmacol., 2005, 69(2), 307-318.
328. Igura, K.; Ohta, T.; Kuroda, Y.; Kaji, K. Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer lett., 2001, 171(1), 11-16.
329. Xiao, D.; Singh, S. V. Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo. Cancer Res., 2007, 67(5), 2239-2246.
330. Bertl, E.; Bartsch, H.; Gerhäuser, C. Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention. Mol. Cancer Ther., 2006, 5(3), 575-585.
331. Davis, R.; Sing, K. P.; Kurzrock, R.; Shankar, S. Sulforaphane inhibits angiogenesis through activation of FOXO transcription factors. Oncol. Rep., 2009, 22(6), 1473-1478.
332. Heemels, M. T.; Dhand, R.; Allen, L. The biochemistry of apoptosis. Nature. 2000, 407, 770-776.
333. Hengartner, M. O. The biochemistry of apoptosis. Chemistry., 2002, 101(102), 145-153.
334. Sprick, M. R.; Walczak, H. The interplay between the Bcl-2 family and death receptor-mediated apoptosis. Biochim. Biophys. Acta., 2004, 1644(2-3), 125-132.
335. Huppertz, B.; Frank, H. G.; Kaufmann, P. The apoptosis cascade- morphological and immunohistochemical methods for its visualization. Anat. Embryol (Berl)., 1999, 200(1), 1-18.
336. Lorenzo, H. K.; Susin, S. A. Mitochondrial effectors in caspaseindependent cell death. FEBS Lett., 2004, 557(1-3), 14-20.
337. Ulukaya, E.; Acilan, C.; Yilmaz, Y. Apoptosis: why and how does it occur in biology? Cell. Biochem. Funct., 2011, 29(6), 468-80.
338. Gogada, R.; Prabhu, V.; Amadori, M.; Scott, R.; Hashmi, S.; Chandra, D. Resveratrol Induces p53-Independent, XIAP-Mediated Bax Oligomerization on Mitochondria to Initiate Cytochrome c Release and Caspase Activation. J. Biol. Chem., 2011, 286(33), 28749-60.
339. Vogelstein, B.; Lane, D.; Levine, A. J. Surfing the p53 network. Nature., 2000, 408(6810), 307-310.
340. Hainaut, P.; Hollstein, M. p53 and human cancer: the first ten thousand mutations. Adv. Cancer Res., 1999, 77, 81-86, 86a, 87-137.
341. Zanotto-Filho, A.; Braganhol, E.; Edelweiss, M. I.; Behr, G. A.; Zanin, R.; Schröder, R.; Simões-Pires, A.; Battastini, A. M. O.; Moreira, J. C. F. The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma. J. Nutr. Biochem., 2011. Jul 18. [Epub ahead of print].
342. Ibrahim, A.; El-meligy, A.; Lungu, G.; Fetaih, H.; Dessouki, A.; Stoica, G.; Barhoumi, R. Curcumin induces apoptosis in a murine mammary gland adenocarcinoma cell line through the mitochondrial pathway. Eur. J. Pharmacol., 2011, 668(1-2), 127-32.
343. Liu, H. S.; Ke, C. S.; Cheng, H. C.; Huang, C. Y. F.; Su, C. L. Curcumin-induced Mitotic Spindle Defect and Cell Cycle Arrest in Human Bladder Cancer Cells is partly through Inhibition of Aurora-A. Mol. Pharmacol., 2011, 80(4), 638-46.
344. Liao, Y. F.; Hung, H. C.; Hour, T. C.; Hsu, P. C.; Kao, M. C.; Tsay, G. J.; Liu, G. Y. Curcumin induces apoptosis through an ornithine decarboxylase-dependent pathway in human promyelocytic leukemia HL-60 cells. Life Sci., 2008, 82(7-8), 367-375.
345. Walters, D. K.; Muff, R.; Langsam, B.; Born, W.; Fuchs, B. Cytotoxic effects of curcumin on osteosarcoma cell lines. Invest. New Drugs., 2008, 26(4), 289-297.
346. Wu, S. H.; Hang, L. W. E. N.; Yang, J. A. I. S.; Chen, H. Y. I.; Lin, H. U. I. Y. I.; Chiang, J. O. H. U. A.; Lu, C. H. I. C.; Yang, J. L.; Lai, T. Y.; Ko, Y. C. Curcumin induces apoptosis in human nonsmall cell lung cancer NCI-H460 cells through ER stress and caspase cascade-and mitochondria-dependent pathways. Anticancer Res., 2010, 30(6), 2125-2133.
347. Bhaumik, S.; Anjum, R.; Rangaraj, N.; Pardhasaradhi, B.; Khar, A. Curcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediates. FEBS Lett., 1999, 456(2), 311-314.
348. Mukhopadhyay, A.; Bueso-Ramos, C.; Chatterjee, D.; Pantazis, P.; Aggarwal, B. B. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene., 2001, 20(52), 7597-7609.
349. Anto, R. J.; Mukhopadhyay, A.; Denning, K.; Aggarwal, B. B. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis., 2002, 23(1), 143-150.
350. Morin, D.; Barthélémy, S.; Zini, R.; Labidalle, S.; Tillement, J. P. Curcumin induces the mitochondrial permeability transition pore mediated by membrane protein thiol oxidation. FEBS Lett., 2001, 495(1-2), 131-136.
351. Aziz, M. H.; Nihal, M.; Fu, V. X.; Jarrard, D. F.; Ahmad, N. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3 -kinase/Akt pathway and Bcl-2 family proteins. Mol. Cancer Ther., 2006, 5(5), 1335-1341.
352. Lin, H.; Xiong, W.; Zhang, X.; Liu, B.; Zhang, W.; Zhang, Y.; Cheng, J.; Huang, H. Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells. Oncol. Rep., 2011, 26(4), 925-30.
353. Lim, Y. C.; Cha, Y. Y. Epigallocatechin 3 gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex. J. Surg. Oncol., 2011, 104(7), 776-80.
354. Choi, E. J.; Kim, G. H. Apigenin induces apoptosis through a mitochondria/caspase-pathway in human breast cancer MDA-MB-453 cells. J. Clin. Biochem. Nutr., 2009, 44(3), 260-265.
355. Xuemei, W.; Fan, Z.; Ling, Y.; Ying, M.; Hai, L.; Xiaowen, Z.; Jialing, Z. Ursolic Acid Inhibits Proliferation and Induces Apoptosis of Cancer Cells In Vitro and In Vivo. J. Biomed. Biotechnol., 2011, 2011, 419343. Epub 2011 May 30.
356. Granado-Serrano, A. B.; Martín, M. A.; Bravo, L.; Goya, L.; Ramos, S. Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2). J. Nutr., 2006, 136(11), 2715-2721.
357. Nesaretnam, K.; Meganathan, P. Tocotrienols: inflammation and cancer. Ann. N. Y. Acad. Sci., 2011, 1229(1), 18-22.
358. Mukherjee, D.; Nissen, S. E.; Topol, E. J. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA., 2001, 286(8), 954-959.
359. Xing, L. L.; Wang, Z. N.; Jiang, L.; Zhang, Y.; Xu, Y. Y.; Li, J.; Luo, Y.; Zhang, X. Cyclooxygenase 2 polymorphism and colorectal cancer:-765G> C variant modifies risk associated with smoking and body mass index. World J. Gastroenterol., 2008, 14(11), 1785.
360. Brown, J. R.; DuBois, R. N. COX-2: a molecular target for colorectal cancer prevention. J. Clin. Oncol., 2005, 23(12), 2840-2855.
361. Eberhart, C. E.; Coffey, R.; Radhika, A.; Giardiello, F.; Ferrenbach, S.; DuBois, R. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994, 107(4), 1183-1188.
362. Cai, Y.; Lee, Y. F.; Li, G.; Liu, S.; Bao, B. Y.; Huang, J.; Hsu, C. L.; Chang, C. A new prostate cancer therapeutic approach: Combination of androgen ablation with COX 2 inhibitor. Int. J. Cancer., 2008, 123(1), 195-201.
363. Aparicio Gallego, G.; Diaz Prado, S.; Jimenez Fonseca, P.; Garcia Campelo, R.; Cassinello Espinosa, J.; Anton Aparicio, L. Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer. Clin. Transl. Oncol., 2007, 9(11), 694-702.
364. Zhao, X.; Goswami, M.; Pokhriyal, N.; Ma, H.; Du, H.; Yao, J.; Victor, T. A.; Polyak, K.; Sturgis, C. D.; Band, H. Cyclooxygenase-2 expression during immortalization and breast cancer progression. Cancer Res., 2008, 68(2), 467-475.
365. Dore, M.; Lanthier, I.; Sirois, J. Cyclooxygenase-2 expression in canine mammary tumors. Vet. Pathol., 2003, 40(2), 207-212.
366. Cerella, C.; Sobolewski, C.; Dicato, M.; Diederich, M. Targeting COX-2 expression by natural compounds: A promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapy. Biochem. Pharmacol., 2010, 80(12), 1801-1815.
367. Plummer, S. M.; Holloway, K. A.; Manson, M. M.; Munks, R. J. L.; Kaptein, A.; Farrow, S.; Howells, L. Inhibition of cyclooxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kB activation via the NIK/IKK signalling complex. Oncogene., 1999, 18(44), 6013-6020.
368. Arber, N.; Eagle, C. J.; Spicak, J.; Rácz, I.; Dite, P.; Hajer, J.; Zavoral, M.; Lechuga, M. J.; Gerletti, P.; Tang, J. Celecoxib for the prevention of colorectal adenomatous polyps. N. Engl. J. Med., 2006, 355(9), 885-895.
369. Lev-Ari, S.; Strier, L.; Kazanov, D.; Madar-Shapiro, L.; Dvory-Sobol, H.; Pinchuk, I.; Marian, B.; Lichtenberg, D.; Arber, N. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clin. Cancer Res., 2005, 11(18), 6738-6744.
370. Xiao, J.; Tan, Y.; Pan, Y.; Liang, G.; Qu, C.; Zhang, X.; Zhang, Y.; Li, X.; Yang, H. A New Cyclooxygenase-2 Inhibitor,(1E, 4E)-1, 5-Bis (2-bromophenyl) penta-1, 4-dien-3-one (GL63) Suppresses Cyclooxygenase-2 Gene Expression in Human Lung Epithelial Cancer Cells: Coupled mRNA Stabilization and Posttranscriptional Inhibition. Biol. Pharm. Bull., 2010, 33(7), 1170-1175.
371. Wang, B.; Zhai, C.; Fang, W.; Chen, X.; Jiang, K.; Wang, Y. The inhibitory effect of curcumin on the proliferation of HT-29 colonic cancer cell induced by deoxycholic acid. Zhonghua Nei Ke Za Zhi., 2009, 48(9), 760-763.
372. Uchiyama, T.; Toda, K.; Takahashi, S. Resveratrol inhibits angiogenic response of cultured endothelial F-2 cells to vascular endothelial growth factor, but not to basic fibroblast growth factor. Biol. Pharm. Bull., 2010, 33(7), 1095-1100.
373. Lau, G. T. Y.; Leung, L. K. The dietary flavonoid apigenin blocks phorbol 12-myristate 13-acetate-induced COX-2 transcriptional activity in breast cell lines. Food Chem. Toxicol., 2010, 48(10), 3022-7.
374. Tahanian, E.; Sanchez, L. A.; Shiao, T. C.; Roy, R.; Annabi, B. Flavonoids targeting of I B phosphorylation abrogates carcinogeninduced MMP-9 and COX-2 expression in human brain endothelial cells. Drug Des. Devel. Ther., 2011, 5, 299-309.
375. Kang, O. H.; Lee, J. H.; Kwon, D. Y. Apigenin inhibits release of inflammatory mediators by blocking the NF-B activation pathways in the HMC-1 cells. Immunopharmacol. Immunotoxicol., 2010, (00), 1-7.
376. Huang, G. S.; Tseng, C. Y.; Lee, C. H.; Su, S. L.; Lee, H. S. Effects of (-)-epigallocatechin-3-gallate on cyclooxygenase 2, PGE 2, and IL-8 expression induced by IL-1 in human synovial fibroblasts. Rheumatol. Int., 2010, 30(9), 1197-1203.
377. Heinecke, L.; Grzanna, M.; Au, A.; Mochal, C.; Rashmir-Raven, A.; Frondoza, C. Inhibition of cyclooxygenase-2 expression and prostaglandin E2 production in chondrocytes by avocado soybean unsaponifiables and epigallocatechin gallate. Osteoarthritis Cartilage., 2010, 18(2), 220-227.
378. Hwang, J. T.; Lee, Y. K.; Shin, J. I.; Park, O. J. Anti inflammatory and Anticarcinogenic Effect of Genistein Alone or in Combination with Capsaicin in TPA Treated Rat Mammary Glands or Mammary Cancer Cell Line. Ann. N. Y. Acad. Sci., 2009, 1171(1), 415-420.
379. Darnell, J.; Kerr, I. M.; Stark, G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science., 1994, 264(5164), 1415-1421.
380. Turkson, J. STAT proteins as novel targets for cancer drug discovery. Expert Opin. Ther. Targets., 2004, 8(5), 409-422.
381. Mitchell, T. J.; John, S. Signal transducer and activator of transcription (STAT) signalling and T cell lymphomas. Immunology. 2005, 114(3), 301-312.
382. Sato, T.; Neilson, L. M.; Peck, A. R.; Liu, C.; Tran, T. H.; Witkiewicz, A.; Hyslop, T.; Nevalainen, M. T.; Sauter, G.; Rui, H. Signal transducer and activator of transcription-3 and breast cancer prognosis. Am. J. Cancer Res., 2011, 1(3), 347-55.
383. Huang, M.; Page, C.; Reynolds, R. K.; Lin, J. Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells. Gynecol. Oncol., 2000, 79(1), 67-73.
384. Bromberg, J. F.; Wrzeszczynska, M. H.; Devgan, G.; Zhao, Y.; Pestell, R. G.; Albanese, C.; Darnell, J. E. Stat3 as an Oncogene. Cell., 1999, 98(3), 295-303.
385. Catlett-Falcone, R.; Landowski, T. H.; Oshiro, M. M.; Turkson, J.; Levitzki, A.; Savino, R.; Ciliberto, G.; Moscinski, L.; Fernández-Luna, J. L.; Nuez, G. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity., 1999, 10(1), 105-115.
386. Shen, Y.; Devgan, G.; Darnell, J. E.; Bromberg, J. F. Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UVinduced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc. Natl. Acad. Sci. U. S. A., 2001, 98(4), 1543-1548.
387. Garcia, R.; Bowman, T. L.; NIU, G.; HUA, Y.; Minton, S.; Muro-Cacho, C. A.; Cox, C. E.; Falcone, R.; Fairclough, R.; Parsons, S. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene., 2001, 20(20), 2499-2513.
388. Catlett-Falcone, R.; Dalton, W. S.; Jove, R. STAT proteins as novel targets for cancer therapy. Curr. Opin. Oncol., 1999, 11(6), 490-496.
389. Bharti, A. C.; Donato, N.; Aggarwal, B. B. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J. Immunol., 2003, 171(7), 3863-3871.
390. Carro, M. S.; Lim, W. K.; Alvarez, M. J.; Bollo, R. J.; Zhao, X.; Snyder, E. Y.; Sulman, E. P.; Anne, S. L.; Doetsch, F.; Colman, H. The transcriptional network for mesenchymal transformation of brain tumours. Nature., 2009, 463(7279), 318-325.
391. Weissenberger, J.; Priester, M.; Bernreuther, C.; Rakel, S.; Glatzel, M.; Seifert, V.; Kögel, D. Dietary Curcumin Attenuates Glioma Growth in a Syngeneic Mouse Model by Inhibition of the JAK1, 2/STAT3 Signaling Pathway. Clin. Cancer Res., 2010, 16(23), 5781-5795.
392. Saydmohammed, M.; Joseph, D.; Syed, V. Curcumin suppresses constitutive activation of STAT 3 by up regulating protein inhibitor of activated STAT 3 (PIAS 3) in ovarian and endometrial cancer cells. J. Cell. Biochem., 2010, 110(2), 447-456.
393. Zhu, B.; Zhan, W.; He, Y.; Cai, S.; Wang, Z.; Zhang, C. Epigallocatechin-3-gallate inhibits growth and angiogenesis of gastric cancer and its molecular mechanism. Zhonghua Wei Chang Wai Ke Za Zhi., 2009, 12(1), 82-85.
394. Park, G.; Yoon, B. S.; Moon, J. H.; Kim, B.; Jun, E. K.; Oh, S.; Kim, H.; Song, H. J.; Noh, J. Y.; Oh, C. H. Green tea polyphenol epigallocatechin-3-gallate suppresses collagen production and proliferation in keloid fibroblasts via inhibition of the STAT3-signaling pathway. J. Invest. Dermatol., 2008, 128(10), 2429-2441.
395. Masuda, M.; Suzui, M.; Weinstein, I. B. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin. Cancer Res., 2001, 7(12), 4220-4229.
396. Masuda, M.; Suzui, M.; Lim, J. T. E.; Weinstein, I. B. Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clin. Cancer Res., 2003, 9(9), 3486-3491.
397. Ansó, E.; Zuazo, A.; Irigoyen, M.; Urdaci, M. C.; Rouzaut, A.; Martínez-Irujo, J. J. Flavonoids inhibit hypoxia-induced vascular endothelial growth factor expression by a HIF-1 independent mechanism. Biochem. Pharmacol., 2010, 79(11), 1600-1609.
398. Selvendiran, K.; Koga, H.; Ueno, T.; Yoshida, T.; Maeyama, M.; Torimura, T.; Yano, H.; Kojiro, M.; Sata, M. Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids. Cancer Res., 2006, 66(9), 4826-4834.
399. Wung, B.; Hsu, M.; Wu, C.; Hsieh, C. Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endothelial cells: effects on the inhibition of STAT3 phosphorylation. Life Sci., 2005, 78(4), 389-397.
400. Wen, S.; Li, H.; Wu, M. L.; Fan, S. H.; Wang, Q.; Shu, X. H.; Kong, Q. Y.; Chen, X. Y.; Liu, J. Inhibition of NF-B signaling commits resveratrol-treated medulloblastoma cells to apoptosis without neuronal differentiation. J. Neurooncol., 2011, 104(1), 169-77.
401. Yang, Y. P.; Chang, Y. L.; Huang, P. I.; Chiou, G. Y.; Tseng, L. M.; Chiou, S. H.; Chen, M. H.; Chen, M. T.; Shih, Y. H.; Chang, C. H. Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis. J. Cell. Physiol., 2011. [Epub ahead of print].
402. Choi, J. S.; Kang, S. W.; Li, J.; Kim, J. L.; Bae, J. Y.; Kim, D. S.; Shin, S. Y.; Jun, J. G.; Wang, M. H.; Kang, Y. H. Blockade of oxidized LDL-triggered endothelial apoptosis by quercetin and rutin through differential signaling pathways involving JAK2. J. Agric. Food Chem., 2009, 57(5), 2079-2086.
403. Muthian, G.; Bright, J. J. Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte. J. Clin. Immunol., 2004, 24(5), 542-552.
404. Pathak, A. K.; Bhutani, M.; Nair, A. S.; Ahn, K. S.; Chakraborty, A.; Kadara, H.; Guha, S.; Sethi, G.; Aggarwal, B. B. Ursolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cells. Mol. Cancer Res., 2007, 5(9), 943-955.
405. Min, L.; He, B.; Hui, L. Mitogen-activated protein kinases in hepatocellular carcinoma development. Semin. Cancer Biol., 2011, 21(1), 10-20. Epub 2010/10/26.
406. Brzezianska, E.; Pastuszak-Lewandoska, D. A minireview: the role of MAPK/ERK and PI3K/Akt pathways in thyroid follicular cellderived neoplasm. Front Biosci., 2011, 16, 422-439.
407. McCubrey, J. A.; Steelman, L. S.; Abrams, S. L.; Lee, J. T.; Chang, F.; Bertrand, F. E.; Navolanic, P. M.; Terrian, D. M.; Franklin, R. A.; D'Assoro, A. B. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance. Adv. Enzyme Regul., 2006, 46(1), 249-279.
408. Steelman, L.; Pohnert, S.; Shelton, J.; Franklin, R.; Bertrand, F.; McCubrey, J. JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCRABL in cell cycle progression and leukemogenesis. Leukemia., 2004, 18(2), 189-218.
409. Garnett, M. J.; Marais, R. Guilty as charged:: B-RAF is a human Oncogene., Cancer Cell., 2004, 6(4), 313-319.
410. Enslen, H.; Raingeaud, J.; Davis, R. J. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J. Biol. Chem., 1998, 273(3), 1741-1748.
411. Keller, D.; Zeng, X.; Li, X.; Kapoor, M.; Iordanov, M. S.; Taya, Y.; Lozano, G.; Magun, B.; Lu, H. The p38MAPK inhibitor SB203580 alleviates ultraviolet-induced phosphorylation at serine 389 but not serine 15 and activation of p53. Biochem. Biophys. Res. Commun., 1999, 261(2), 464-471.
412. Sanchez-Prieto, R.; Rojas, J. M.; Taya, Y.; Gutkind, J. S. A role for the p38 mitogen-activated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents. Cancer Res., 2000, 60(9), 2464-2472.
413. Thomas, S. L.; Zhao, J.; Li, Z.; Lou, B.; Du, Y.; Purcell, J.; Snyder, J. P.; Khuri, F. R.; Liotta, D.; Fu, H. Activation of the p38 pathway by a novel monoketone curcumin analog, EF24, suggests a potential combination strategy. Biochem. Pharmacol., 2010, 80(9), 1309-1316.
414. Hua, W. F.; Fu, Y. S.; Liao, Y. J.; Xia, W. J.; Chen, Y. C.; Zeng, Y. X.; Kung, H. F.; Xie, D. Curcumin induces down-regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells. Eur. J. Pharmacol., 2010, 637(1-3), 16-21.
415. Weir, N. M.; Selvendiran, K.; Kutala, V. K.; Tong, L.; Vishwanath, S.; Rajaram, M.; Tridandapani, S.; Anant, S.; Kuppusamy, P. Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer Biol. Ther., 2007, 6(2), 178-184.
416. Woo, M. S.; Jung, S. H.; Kim, S. Y.; Hyun, J. W.; Ko, K. H.; Kim, W. K.; Kim, H. S. Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells. Biochem. Biophys. Res. Commun., 2005, 335(4), 1017-1025.
417. Filomeni, G.; Graziani, I.; Rotilio, G.; Ciriolo, M. trans-Resveratrol induces apoptosis in human breast cancer cells MCF-7 by the activation of MAP kinases pathways. Genes Nutr., 2007, 2(3), 295-305.
418. Sánchez-Fidalgo, S.; Cárdeno, A.; Villegas, I.; Talero, E.; de la Lastra, C. A. Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice. Eur. J. Pharmacol., 2010, 633(1-3), 78-84.
419. Noh, H. J.; Sung G.E. G.; Kim, J. Y.; Lee, T. J.; Song, I. H. Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by apigenin via the inhibition of p38 mitogen-activated protein kinase-dependent matrix metalloproteinase-9 expression. Oncol. Rep., 2010, 24(1), 277-283.
420. Shukla, S.; Gupta, S. Apigenin-Induced Cell Cycle Arrest is Mediated by Modulation of MAPK, PI3K-Akt and Loss of Cyclin D1 Associated Retinoblastoma Dephosphorylation in Human Prostate Cancer Cells. Cell Cycle., 2007, 6(9), 1102-1114.
421. Cavet, M. E.; Harrington, K. L.; Vollmer, T. R.; Ward, K. W.; Zhang, J. Z. Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells. Mol. Vis., 2011, 17, 533-542.
422. Yang, D.; Liu, J.; Tian, C.; Zeng, Y.; Zheng, Y.; Fang, Q.; Li, H. Epigallocatechin gallate inhibits angiotensin II-induced endothelial barrier dysfunction via inhibition of the p38 MAPK/HSP27 pathway. Acta Pharmacol. Sin., 2010, 31(10), 1401-1406.
423. Shan, J.; Xuan, Y.; Zheng, S.; Dong, Q.; Zhang, S. Ursolic acid inhibits proliferation and induces apoptosis of HT-29 colon cancer cells by inhibiting the EGFR/MAPK pathway. J. Zhejiang Univ. Sci. B., 2009, 10(9), 668-674.
424. Lee, Y. S.; Sohn, K. C.; Kim, K. H.; Cho, M. J.; Hur, G. M.; Yoon, T. J.; Kim, S. K.; Lee, K.; Lee, J. H.; Kim, C. D. Role of protein kinase C delta in X ray induced apoptosis of keratinocyte. Exp. Dermatol., 2009, 18(1), 50-56.
425. Araújo, J. R.; Gon alves, P.; Martel, F. Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines. Nutr. Res., 2011, 31(2), 77-87.
426. Ramos, S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J. Nutr. Biochem., 2007, 18(7), 427-442.
427. Jun, D. Y.; Park, H. S.; Kim, J. S.; Park, W.; Song, B. H.; Kim, H. S.; Taub, D.; Kim, Y. H. 17 [alpha]-Estradiol arrests cell cycle progression at G2/M and induces apoptotic cell death in human acute leukemia Jurkat T cells. Toxicol. Appl. Pharmacol., 2008, 231(3), 401-412.
428. Kuo, P. L.; Chen, C. Y.; Tzeng, T. F.; Lin, C. C.; Hsu, Y. L. Involvement of reactive oxygen species/c-Jun NH2-terminal kinase pathway in kotomolide A induces apoptosis in human breast cancer cells. Toxicol. Appl. Pharmacol., 2008, 229(2), 215-226.
429. Sánchez, C. A.; Rodríguez, E.; Varela, E.; Zapata, E.; Páez, A.; Massó, F. A.; Montaño, L. F.; López-Marure, R. Statin-induced inhibition of MCF-7 breast cancer cell proliferation is related to cell cycle arrest and apoptotic and necrotic cell death mediated by an enhanced oxidative stress. Cancer invest., 2008, 26(7), 698-707.
430. Lu, J. J.; Cai, Y. J.; Ding, J. Curcumin induces DNA damage and caffeine-insensitive cell cycle arrest in colorectal carcinoma HCT116 cells. Mol. Cell. Biochem., 2011, 354(1-2), 247-52.
431. LEE, D. U. K. S. U.; LEE, M. I. K.; KIM, J. H. E. E. Curcumin induces cell cycle arrest and apoptosis in human osteosarcoma (HOS) cells. Anticancer Res., 2009, 29(12), 5039-5044.
432. Zhang, Q.; Zhao, X. H.; Wang, Z. J. Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G2/M arrest and apoptosis. Toxicol In Vitro., 2009, 23(5), 797-807.
433. Cui, J.; Sun, R.; Yu, Y.; Gou, S.; Zhao, G.; Wang, C. Antiproliferative effect of resveratrol in pancreatic cancer cells. Phytother. Res., 2010, 24(11), 1637-1644.
434. Cai, J.; Zhao, X. L.; Liu, A. W.; Nian, H.; Zhang, S. H. Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns. Phytomedicine., 2011, 18(5), 366-373.
435. Ruela-de-Sousa, R.; Fuhler, G.; Blom, N.; Ferreira, C.; Aoyama, H.; Peppelenbosch, M. Cytotoxicity of apigenin on leukemia cell lines: implications for prevention and therapy. Cell Death Dis., 2010, 1(1), e19.
436. Jakubikova, J.; Cervi, D.; Ooi, M.; Kim, K.; Nahar, S.; Klippel, S.; Cholujova, D.; Leiba, M.; Daley, J. F.; Delmore, J. Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and PEITC in multiple myeloma. Haematologica., 2011, 96(8), 1170-9.
437. Karin, M.; Liu, Z.; Zandi, E. AP-1 function and regulation. Curr. Opin. Cell. Biol., 1997, 9(2), 240-246.
438. Patel, V. B.; Misra, S.; Patel, B. B.; Majumdar, A. P. N. Colorectal cancer: chemopreventive role of curcumin and resveratrol. Nutr. Cancer., 2010, 62(7), 958-967.
439. Shehzad, A.; Wahid, F.; Lee, Y. S. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch. Pharm (Weinheim)., 2010, 343(9), 489-99.
440. Young, M. R.; Li, J. J.; Rincón, M.; Flavell, R. A.; Sathyanarayana, B.; Hunziker, R.; Colburn, N. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc. Natl. Acad. Sci. U. S. A., 1999, 96(17), 9827-9832.
441. Funakoshi Tago, M.; Tago, K.; Sonoda, Y.; Tominaga, S.; Kasahara, T. TRAF6 and C SRC induce synergistic AP 1 activation via PI3 kinase-AKT-JNK pathway. Eur. J. Biochem., 2003, 270(6), 1257-1268.
442. Aggarwal, B. B.; Shishodia, S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol., 2006, 71(10), 1397-1421.
443. Matthews, C. P.; Colburn, N. H.; Young, M. R. AP-1 a target for cancer prevention. Curr. Cancer Drug Targets. 2007, 7(4), 317-324.
444. Jacobs-Helber, S. M.; Wickrema, A.; Birrer, M. J.; Sawyer, S. T. AP1 regulation of proliferation and initiation of apoptosis in erythropoietin-dependent erythroid cells. Mol. Cell. Biol., 1998, 18(7), 3699-3707.
445. Dhandapani, K. M.; Mahesh, V. B.; Brann, D. W. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP 1 and NF B transcription factors. J. Neurochem., 2007, 102(2), 522-538.
446. Jang, M.; Pezzuto, J. M. Effects of resveratrol on 12-Otetradecanoylphorbol-13-acetate-induced oxidative events and gene expression in mouse skin. Cancer lett., 1998, 134(1), 81-89.
447. Yun, H. J.; Yoo, W. H.; Han, M. K.; Lee, Y. R.; Kim, J. S.; Lee, S. I. Epigallocatechin-3-gallate suppresses TNF-alpha -induced production of MMP-1 and -3 in rheumatoid arthritis synovial fibroblasts. Rheumatol. Int., 2008, 29(1), 23-29.
448. Nair, S.; Barve, A.; Khor, T. O.; Shen, G.; Lin, W.; Chan, J. Y.; Cai, L.; Kong, A. N. Regulation of Nrf2-and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells. Acta Pharmacol. Sin., 2010, 31(9), 1223-40.
449. Lim, H.; Park, H.; Kim, H. P. Effects of Flavonoids on Matrix Metalloproteinase-13 Expression of Interleukin-1 -Treated Articular Chondrocytes and Their Cellular Mechanisms: Inhibition of c-Fos/AP-1 and JAK/STAT Signaling Pathways. J. Pharmacol. Sci., 2011, 116(2), 221-231.
450. Hwang, Y. P.; Oh, K. N.; Yun, H. J.; Jeong, H. G. The flavonoids apigenin and luteolin suppress ultraviolet A-induced matrix metalloproteinase-1 expression via MAPKs and AP-1-dependent signaling in HaCaT cells. J. Dermatol. Sci., 2011, 61(1), 23-31.
451. Li, Z.; Li, J.; Mo, B.; Hu, C.; Liu, H.; Qi, H.; Wang, X.; Xu, J., editors. Genistein induces G 2/M cell cycle arrest via stable activation of ERK1/2 pathway in MDA-MB-231 breast cancer cells. 2009: Springer.